{
  "entities": [
    {
      "id": "E1",
      "type": "Target",
      "name": "cAMP-signaling pathway",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "2b1b0fb78e7bf9d3917894168b0d5e5b"
      ],
      "confidence": 0.9,
      "evidence": "cAMP-signaling pathway in the nucleus accumbens",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "Phosphodiesterase 4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "2b1b0fb78e7bf9d3917894168b0d5e5b"
      ],
      "confidence": 0.95,
      "evidence": "Phosphodiesterase 4 (PDE4) is an enzyme",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "2b1b0fb78e7bf9d3917894168b0d5e5b"
      ],
      "confidence": 0.9,
      "evidence": "Phosphodiesterase 4 (PDE4)",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "drug tolerance",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "2b1b0fb78e7bf9d3917894168b0d5e5b"
      ],
      "confidence": 0.85,
      "evidence": "underlie aspects of drug tolerance",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "dependence",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "2b1b0fb78e7bf9d3917894168b0d5e5b"
      ],
      "confidence": 0.85,
      "evidence": "underlie aspects of drug tolerance and dependence",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "up-regulation of cAMP-signaling pathway",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "2b1b0fb78e7bf9d3917894168b0d5e5b"
      ],
      "confidence": 0.8,
      "evidence": "causes an up-regulation of the cAMP-signaling pathway",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "hydrolyzes intracellular cAMP",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "2b1b0fb78e7bf9d3917894168b0d5e5b"
      ],
      "confidence": 0.8,
      "evidence": "selective hydrolyzes intracellular cAMP",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "46817a691bbdc4285014bccc8ae83f6a"
      ],
      "confidence": 0.9,
      "evidence": "PDE4 inhibitors",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Effect",
      "name": "reduce drug intake",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "46817a691bbdc4285014bccc8ae83f6a"
      ],
      "confidence": 0.85,
      "evidence": "reduce drug intake",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Effect",
      "name": "reduce drug seeking",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "46817a691bbdc4285014bccc8ae83f6a"
      ],
      "confidence": 0.85,
      "evidence": "reduce drug seeking",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "psychostimulant use",
      "attributes": {
        "condition_type": "substance use disorder"
      },
      "source_chunk_ids": [
        "46817a691bbdc4285014bccc8ae83f6a"
      ],
      "confidence": 0.8,
      "evidence": "psychostimulants",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "alcohol use",
      "attributes": {
        "condition_type": "substance use disorder"
      },
      "source_chunk_ids": [
        "46817a691bbdc4285014bccc8ae83f6a"
      ],
      "confidence": 0.8,
      "evidence": "alcohol",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "opioid use",
      "attributes": {
        "condition_type": "substance use disorder"
      },
      "source_chunk_ids": [
        "46817a691bbdc4285014bccc8ae83f6a"
      ],
      "confidence": 0.8,
      "evidence": "opioids",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Evidence",
      "name": "animal studies",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "46817a691bbdc4285014bccc8ae83f6a"
      ],
      "confidence": 0.85,
      "evidence": "studies have shown in rats or mice",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "449c3c7682d3812e3c88a8129f5d60a7"
      ],
      "confidence": 0.95,
      "evidence": "PDE4 could be a therapeutic target",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "substance use disorder",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "449c3c7682d3812e3c88a8129f5d60a7"
      ],
      "confidence": 0.9,
      "evidence": "substance use disorder",
      "verified": true
    },
    {
      "id": "E3",
      "type": "CompoundClass",
      "name": "PDE4 inhibitors",
      "attributes": {},
      "source_chunk_ids": [
        "449c3c7682d3812e3c88a8129f5d60a7"
      ],
      "confidence": 0.9,
      "evidence": "PDE4 inhibitors",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "drug addiction",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "449c3c7682d3812e3c88a8129f5d60a7"
      ],
      "confidence": 0.85,
      "evidence": "drug addiction",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Evidence",
      "name": "preclinical studies",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "449c3c7682d3812e3c88a8129f5d60a7"
      ],
      "confidence": 0.8,
      "evidence": "Preclinical studies suggest",
      "verified": true
    },
    {
      "id": "E6",
      "type": "AdverseEvent",
      "name": "side effects",
      "attributes": {
        "severity": "limiting"
      },
      "source_chunk_ids": [
        "449c3c7682d3812e3c88a8129f5d60a7"
      ],
      "confidence": 0.75,
      "evidence": "side effects that limit the clinical potential",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Condition",
      "name": "drug addiction",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "891928bec7637c2d4902145f4426753c"
      ],
      "confidence": 0.9,
      "evidence": "Drug addiction",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "alcohol dependence",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "891928bec7637c2d4902145f4426753c"
      ],
      "confidence": 0.9,
      "evidence": "alcohol dependence",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "891928bec7637c2d4902145f4426753c"
      ],
      "confidence": 0.85,
      "evidence": "phosphodiesterase 4 (PDE4)",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "reduce drug intake",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "891928bec7637c2d4902145f4426753c"
      ],
      "confidence": 0.8,
      "evidence": "reduce drug intake",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "reduce drug seeking",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "891928bec7637c2d4902145f4426753c"
      ],
      "confidence": 0.8,
      "evidence": "reduce drug seeking",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "psychostimulant addiction",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "891928bec7637c2d4902145f4426753c"
      ],
      "confidence": 0.85,
      "evidence": "addiction to psychostimulants",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Evidence",
      "name": "animal models",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "891928bec7637c2d4902145f4426753c"
      ],
      "confidence": 0.75,
      "evidence": "animal models",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "aeed08f92815866e113bc2e79743ce0f"
      ],
      "confidence": 0.95,
      "evidence": "PDE4 is a cAMP-specific phosphodiesterase",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "substance use disorder",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "aeed08f92815866e113bc2e79743ce0f"
      ],
      "confidence": 0.9,
      "evidence": "therapeutic target for several classes of substance use disorder",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Effect",
      "name": "reduce drug intake and/or drug seeking",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "aeed08f92815866e113bc2e79743ce0f"
      ],
      "confidence": 0.85,
      "evidence": "PDE4 inhibitors reduce drug intake and/or drug seeking",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "increase in intracellular cAMP levels",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "aeed08f92815866e113bc2e79743ce0f"
      ],
      "confidence": 0.8,
      "evidence": "causes widespread increase in intracellular cAMP levels",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "disrupt or occlude cAMP-related neuroadaptations",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "aeed08f92815866e113bc2e79743ce0f"
      ],
      "confidence": 0.75,
      "evidence": "disrupt or occlude cAMP-related neuroadaptations",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Evidence",
      "name": "preclinical studies",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "aeed08f92815866e113bc2e79743ce0f"
      ],
      "confidence": 0.85,
      "evidence": "In preclinical studies",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Study",
      "name": "review of PDE4 inhibitors and addiction",
      "attributes": {
        "design": "review"
      },
      "source_chunk_ids": [
        "aeed08f92815866e113bc2e79743ce0f"
      ],
      "confidence": 0.8,
      "evidence": "Here, we review the current knowledge",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "Phosphodiesterases",
      "attributes": {
        "target_type": "enzyme family"
      },
      "source_chunk_ids": [
        "70c87099b86a655798c3ca681fc97782"
      ],
      "confidence": 0.95,
      "evidence": "Phosphodiesterases (PDEs) are a family of enzymes",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "70c87099b86a655798c3ca681fc97782"
      ],
      "confidence": 0.9,
      "evidence": "PDE4 has emerged as a potential therapeutic target",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "substance abuse",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "70c87099b86a655798c3ca681fc97782"
      ],
      "confidence": 0.85,
      "evidence": "treatment of substance abuse",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "substance use disorders",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "70c87099b86a655798c3ca681fc97782"
      ],
      "confidence": 0.85,
      "evidence": "treatment of substance use disorders",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "7fc036ed2c2620a6526512810eb2e3ed"
      ],
      "confidence": 0.9,
      "evidence": "PDE4 has four isoforms",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "PDE4A",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "7fc036ed2c2620a6526512810eb2e3ed"
      ],
      "confidence": 0.85,
      "evidence": "PDE4A",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "PDE4B",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "7fc036ed2c2620a6526512810eb2e3ed"
      ],
      "confidence": 0.85,
      "evidence": "PDE4B",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "PDE4C",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "7fc036ed2c2620a6526512810eb2e3ed"
      ],
      "confidence": 0.85,
      "evidence": "PDE4C",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "PDE4D",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "7fc036ed2c2620a6526512810eb2e3ed"
      ],
      "confidence": 0.85,
      "evidence": "PDE4D",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "4680e584ca7433423b40cfd417fdcd3e"
      ],
      "confidence": 0.9,
      "evidence": "PDE4 has over 30 isoforms",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "PDE4D",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "4680e584ca7433423b40cfd417fdcd3e"
      ],
      "confidence": 0.85,
      "evidence": "PDE4D has 11 variants",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "PDE4A",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "4680e584ca7433423b40cfd417fdcd3e"
      ],
      "confidence": 0.8,
      "evidence": "PDE4A, PDE4B, and PDE4D",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "PDE4B",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "4680e584ca7433423b40cfd417fdcd3e"
      ],
      "confidence": 0.8,
      "evidence": "PDE4A, PDE4B, and PDE4D",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "PDE4C",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "4680e584ca7433423b40cfd417fdcd3e"
      ],
      "confidence": 0.8,
      "evidence": "PDE4C is largely absent",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Study",
      "name": "MacKenzie and Houslay, 2000",
      "attributes": {
        "year": 2000
      },
      "source_chunk_ids": [
        "4680e584ca7433423b40cfd417fdcd3e"
      ],
      "confidence": 0.7,
      "evidence": "MacKenzie and Houslay, 2000",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Study",
      "name": "Wang et al., 2015",
      "attributes": {
        "year": 2015
      },
      "source_chunk_ids": [
        "4680e584ca7433423b40cfd417fdcd3e"
      ],
      "confidence": 0.7,
      "evidence": "Wang et al., 2015",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Study",
      "name": "Johansson et al., 2012",
      "attributes": {
        "year": 2012
      },
      "source_chunk_ids": [
        "4680e584ca7433423b40cfd417fdcd3e"
      ],
      "confidence": 0.7,
      "evidence": "Johansson et al., 2012",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Study",
      "name": "Perez-Torres et al., 2000",
      "attributes": {
        "year": 2000
      },
      "source_chunk_ids": [
        "4680e584ca7433423b40cfd417fdcd3e"
      ],
      "confidence": 0.7,
      "evidence": "Perez-Torres et al., 2000",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Study",
      "name": "Lakics et al., 2010",
      "attributes": {
        "year": 2010
      },
      "source_chunk_ids": [
        "4680e584ca7433423b40cfd417fdcd3e"
      ],
      "confidence": 0.7,
      "evidence": "Lakics et al., 2010",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE4B",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "ecad62b522b0b291519e8b5fe3d6fadc"
      ],
      "confidence": 0.95,
      "evidence": "PDE4B mRNA is high",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "PDE4A",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "ecad62b522b0b291519e8b5fe3d6fadc"
      ],
      "confidence": 0.9,
      "evidence": "PDE4A mRNA levels are present",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "PDE4D",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "ecad62b522b0b291519e8b5fe3d6fadc"
      ],
      "confidence": 0.9,
      "evidence": "PDE4D mRNA levels are present",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "dopamine D1 receptor",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "ecad62b522b0b291519e8b5fe3d6fadc"
      ],
      "confidence": 0.85,
      "evidence": "dopamine D1 receptor-expressing",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "dopamine D2 receptor",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "ecad62b522b0b291519e8b5fe3d6fadc"
      ],
      "confidence": 0.85,
      "evidence": "dopamine D2 receptor-expressing",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Study",
      "name": "Johansson et al., 2012; Lakics et al., 2010; Perez-Torres et al., 2000",
      "attributes": {
        "year": "2012, 2010, 2000"
      },
      "source_chunk_ids": [
        "ecad62b522b0b291519e8b5fe3d6fadc"
      ],
      "confidence": 0.8,
      "evidence": "Johansson et al., 2012; Lakics et al., 2010; Perez-Torres et al., 2000",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Study",
      "name": "Cherry and Davis, 1999; Perez-Torres et al., 2000",
      "attributes": {
        "year": "1999, 2000"
      },
      "source_chunk_ids": [
        "ecad62b522b0b291519e8b5fe3d6fadc"
      ],
      "confidence": 0.8,
      "evidence": "Cherry and Davis, 1999; Perez-Torres et al., 2000",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Study",
      "name": "Graybiel, 1990, 2000",
      "attributes": {
        "year": "1990, 2000"
      },
      "source_chunk_ids": [
        "ecad62b522b0b291519e8b5fe3d6fadc"
      ],
      "confidence": 0.8,
      "evidence": "Graybiel, 1990, 2000",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Study",
      "name": "Nishi et al., 2008",
      "attributes": {
        "year": "2008"
      },
      "source_chunk_ids": [
        "ecad62b522b0b291519e8b5fe3d6fadc"
      ],
      "confidence": 0.8,
      "evidence": "Nishi et al., 2008",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Study",
      "name": "Franklin et al., 2015",
      "attributes": {
        "year": "2015"
      },
      "source_chunk_ids": [
        "ecad62b522b0b291519e8b5fe3d6fadc"
      ],
      "confidence": 0.8,
      "evidence": "Franklin et al., 2015",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "ecad62b522b0b291519e8b5fe3d6fadc"
      ],
      "confidence": 0.7,
      "evidence": "mRNA levels",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Effect",
      "name": "behaviorally stimulating",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "ecad62b522b0b291519e8b5fe3d6fadc"
      ],
      "confidence": 0.75,
      "evidence": "direct pathway is behaviorally stimulating",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Effect",
      "name": "behaviorally suppressant",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "ecad62b522b0b291519e8b5fe3d6fadc"
      ],
      "confidence": 0.75,
      "evidence": "indirect pathway is behaviorally suppressant",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE4A",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "4f33a38c7a2ce01b0bf10011585e4714"
      ],
      "confidence": 0.9,
      "evidence": "PDE4A and 4B mRNA are low",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "PDE4B",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "4f33a38c7a2ce01b0bf10011585e4714"
      ],
      "confidence": 0.9,
      "evidence": "PDE4A and 4B mRNA are low",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "PDE4D",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "4f33a38c7a2ce01b0bf10011585e4714"
      ],
      "confidence": 0.9,
      "evidence": "PDE4D was not detected",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Study",
      "name": "Johansson et al., 2012",
      "attributes": {
        "year": 2012
      },
      "source_chunk_ids": [
        "4f33a38c7a2ce01b0bf10011585e4714"
      ],
      "confidence": 0.85,
      "evidence": "Johansson et al., 2012",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Study",
      "name": "Lakics et al., 2010",
      "attributes": {
        "year": 2010
      },
      "source_chunk_ids": [
        "4f33a38c7a2ce01b0bf10011585e4714"
      ],
      "confidence": 0.85,
      "evidence": "Lakics et al., 2010",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Study",
      "name": "Cherry and Davis, 1999",
      "attributes": {
        "year": 1999
      },
      "source_chunk_ids": [
        "4f33a38c7a2ce01b0bf10011585e4714"
      ],
      "confidence": 0.85,
      "evidence": "Cherry and Davis, 1999",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Study",
      "name": "Perez-Torres et al., 2000",
      "attributes": {
        "year": 2000
      },
      "source_chunk_ids": [
        "4f33a38c7a2ce01b0bf10011585e4714"
      ],
      "confidence": 0.85,
      "evidence": "Perez-Torres et al., 2000",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Study",
      "name": "Franklin et al., 2015",
      "attributes": {
        "year": 2015
      },
      "source_chunk_ids": [
        "4f33a38c7a2ce01b0bf10011585e4714"
      ],
      "confidence": 0.85,
      "evidence": "Franklin et al., 2015",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Evidence",
      "name": "mRNA analysis",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "4f33a38c7a2ce01b0bf10011585e4714"
      ],
      "confidence": 0.8,
      "evidence": "mRNA analyzed by quantitative real-time PCR",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Evidence",
      "name": "protein expression",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "4f33a38c7a2ce01b0bf10011585e4714"
      ],
      "confidence": 0.8,
      "evidence": "Protein expression in rodents",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Effect",
      "name": "low mRNA levels",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "4f33a38c7a2ce01b0bf10011585e4714"
      ],
      "confidence": 0.75,
      "evidence": "PDE4A and 4B mRNA are low",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Effect",
      "name": "mRNA not detected",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "4f33a38c7a2ce01b0bf10011585e4714"
      ],
      "confidence": 0.75,
      "evidence": "PDE4D was not detected",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Effect",
      "name": "elevated mRNA",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "4f33a38c7a2ce01b0bf10011585e4714"
      ],
      "confidence": 0.75,
      "evidence": "PDE4B2 mRNA was elevated",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE4A",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "f02199c8c1b5b80f267b587d4167a1d1"
      ],
      "confidence": 0.9,
      "evidence": "PDE4A, 4B, and 4D are all present",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "PDE4B",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "f02199c8c1b5b80f267b587d4167a1d1"
      ],
      "confidence": 0.9,
      "evidence": "PDE4A, 4B, and 4D are all present",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "PDE4D",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "f02199c8c1b5b80f267b587d4167a1d1"
      ],
      "confidence": 0.9,
      "evidence": "PDE4A, 4B, and 4D are all present",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Study",
      "name": "Cherry and Davis, 1999",
      "attributes": {
        "year": 1999
      },
      "source_chunk_ids": [
        "f02199c8c1b5b80f267b587d4167a1d1"
      ],
      "confidence": 0.85,
      "evidence": "Cherry and Davis, 1999",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Study",
      "name": "Kuroiwa et al., 2012",
      "attributes": {
        "year": 2012
      },
      "source_chunk_ids": [
        "f02199c8c1b5b80f267b587d4167a1d1"
      ],
      "confidence": 0.85,
      "evidence": "Kuroiwa et al., 2012",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Study",
      "name": "Lakics et al., 2010",
      "attributes": {
        "year": 2010
      },
      "source_chunk_ids": [
        "f02199c8c1b5b80f267b587d4167a1d1"
      ],
      "confidence": 0.85,
      "evidence": "Lakics et al., 2010",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "69bcdc3130c9db875524e27476075c78"
      ],
      "confidence": 0.9,
      "evidence": "Studies investigating PDE4",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "PDE4A",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "69bcdc3130c9db875524e27476075c78"
      ],
      "confidence": 0.9,
      "evidence": "low to moderate levels of PDE4A",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "PDE4B",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "69bcdc3130c9db875524e27476075c78"
      ],
      "confidence": 0.9,
      "evidence": "very low to low levels of PDE4B",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "PDE4D",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "69bcdc3130c9db875524e27476075c78"
      ],
      "confidence": 0.9,
      "evidence": "low to moderate levels of PDE4D",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Study",
      "name": "Johansson et al., 2012",
      "attributes": {
        "year": 2012
      },
      "source_chunk_ids": [
        "69bcdc3130c9db875524e27476075c78"
      ],
      "confidence": 0.8,
      "evidence": "Johansson et al., 2012",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Study",
      "name": "Perez-Torres et al., 2000",
      "attributes": {
        "year": 2000
      },
      "source_chunk_ids": [
        "69bcdc3130c9db875524e27476075c78"
      ],
      "confidence": 0.8,
      "evidence": "Perez-Torres et al., 2000",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Study",
      "name": "Franklin et al., 2015",
      "attributes": {
        "year": 2015
      },
      "source_chunk_ids": [
        "69bcdc3130c9db875524e27476075c78"
      ],
      "confidence": 0.8,
      "evidence": "Franklin et al., 2015",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "69bcdc3130c9db875524e27476075c78"
      ],
      "confidence": 0.7,
      "evidence": "Studies investigating PDE4",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE4 isoforms",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "967608e5a5c8b66e1d97fd5b46d09333"
      ],
      "confidence": 0.9,
      "evidence": "distribution of PDE4 isoforms",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "PDE4D",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "967608e5a5c8b66e1d97fd5b46d09333"
      ],
      "confidence": 0.95,
      "evidence": "PDE4D mRNA is the highest",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "PDE4B",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "967608e5a5c8b66e1d97fd5b46d09333"
      ],
      "confidence": 0.9,
      "evidence": "PDE4B is present in modest amounts",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "PDE4A",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "967608e5a5c8b66e1d97fd5b46d09333"
      ],
      "confidence": 0.85,
      "evidence": "PDE4A barely detectable",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Study",
      "name": "Horn et al., 2013",
      "attributes": {
        "year": 2013
      },
      "source_chunk_ids": [
        "967608e5a5c8b66e1d97fd5b46d09333"
      ],
      "confidence": 0.8,
      "evidence": "Horn et al., 2013",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Study",
      "name": "Mori et al., 2010",
      "attributes": {
        "year": 2010
      },
      "source_chunk_ids": [
        "967608e5a5c8b66e1d97fd5b46d09333"
      ],
      "confidence": 0.8,
      "evidence": "Mori et al., 2010",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Study",
      "name": "Perez-Torres et al., 2000",
      "attributes": {
        "year": 2000
      },
      "source_chunk_ids": [
        "967608e5a5c8b66e1d97fd5b46d09333"
      ],
      "confidence": 0.8,
      "evidence": "Perez-Torres et al., 2000",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Study",
      "name": "Cherry and Davis, 1999",
      "attributes": {
        "year": 1999
      },
      "source_chunk_ids": [
        "967608e5a5c8b66e1d97fd5b46d09333"
      ],
      "confidence": 0.8,
      "evidence": "Cherry and Davis, 1999",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "967608e5a5c8b66e1d97fd5b46d09333"
      ],
      "confidence": 0.7,
      "evidence": "mRNA and protein detection",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Mori et al., 2010",
      "attributes": {
        "year": 2010,
        "design": "observational"
      },
      "source_chunk_ids": [
        "7b9af0fbb00b3348fc67553bb9d80568"
      ],
      "confidence": 0.9,
      "evidence": "Mori et al., 2010",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vitro study",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "7b9af0fbb00b3348fc67553bb9d80568"
      ],
      "confidence": 0.8,
      "evidence": "study measuring PDE4 isoforms",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "PDE4D",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "7b9af0fbb00b3348fc67553bb9d80568"
      ],
      "confidence": 0.95,
      "evidence": "PDE4D mRNA was the highest",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "PDE4B",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "7b9af0fbb00b3348fc67553bb9d80568"
      ],
      "confidence": 0.9,
      "evidence": "4B was lower",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "PDE4A",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "7b9af0fbb00b3348fc67553bb9d80568"
      ],
      "confidence": 0.85,
      "evidence": "4A was not detected",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "dorsal vagal motor nucleus",
      "attributes": {
        "target_type": "brain region"
      },
      "source_chunk_ids": [
        "7b9af0fbb00b3348fc67553bb9d80568"
      ],
      "confidence": 0.9,
      "evidence": "dorsal vagal motor nucleus",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "locomotor sensitization",
      "attributes": {
        "target_type": "behavioral process"
      },
      "source_chunk_ids": [
        "bee7a29b02c1447c8b021b6121a1e76a"
      ],
      "confidence": 0.9,
      "evidence": "Locomotor sensitization is a phenomenon",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "conditioned place preference",
      "attributes": {
        "target_type": "behavioral test"
      },
      "source_chunk_ids": [
        "bee7a29b02c1447c8b021b6121a1e76a"
      ],
      "confidence": 0.9,
      "evidence": "conditioned place preference (CPP) test",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "intravenous drug self-administration",
      "attributes": {
        "target_type": "behavioral test"
      },
      "source_chunk_ids": [
        "bee7a29b02c1447c8b021b6121a1e76a"
      ],
      "confidence": 0.9,
      "evidence": "Intravenous drug self-administration",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "reinstatement of drug seeking",
      "attributes": {
        "target_type": "behavioral process"
      },
      "source_chunk_ids": [
        "bee7a29b02c1447c8b021b6121a1e76a"
      ],
      "confidence": 0.9,
      "evidence": "Reinstatement of drug seeking",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "two bottle choice test for alcohol drinking",
      "attributes": {
        "target_type": "behavioral test"
      },
      "source_chunk_ids": [
        "bee7a29b02c1447c8b021b6121a1e76a"
      ],
      "confidence": 0.9,
      "evidence": "two bottle choice test for alcohol drinking",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "intracranial self-stimulation",
      "attributes": {
        "target_type": "behavioral test"
      },
      "source_chunk_ids": [
        "bee7a29b02c1447c8b021b6121a1e76a"
      ],
      "confidence": 0.9,
      "evidence": "Intracranial self-stimulation",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Condition",
      "name": "drug craving",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "bee7a29b02c1447c8b021b6121a1e76a"
      ],
      "confidence": 0.8,
      "evidence": "increased craving following exposure to drug cues",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Condition",
      "name": "drug seeking",
      "attributes": {
        "condition_type": "behavior"
      },
      "source_chunk_ids": [
        "bee7a29b02c1447c8b021b6121a1e76a"
      ],
      "confidence": 0.8,
      "evidence": "reinstatement of drug seeking",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Evidence",
      "name": "drug discrimination test",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "1a0f027a9bfa2d7c8372f363fd5cebb4"
      ],
      "confidence": 0.9,
      "evidence": "Drug discrimination is a test",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Effect",
      "name": "discriminative stimulus effects",
      "attributes": {
        "level": "behavioral",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "1a0f027a9bfa2d7c8372f363fd5cebb4"
      ],
      "confidence": 0.85,
      "evidence": "measures the discriminative stimulus effects",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Effect",
      "name": "subjective feelings",
      "attributes": {
        "level": "behavioral",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "1a0f027a9bfa2d7c8372f363fd5cebb4"
      ],
      "confidence": 0.8,
      "evidence": "Psychoactive drugs produce subjective feelings",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {},
      "source_chunk_ids": [
        "1a0f027a9bfa2d7c8372f363fd5cebb4"
      ],
      "confidence": 0.95,
      "evidence": "cocaine infusion",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Compound",
      "name": "flumazenil",
      "attributes": {},
      "source_chunk_ids": [
        "1a0f027a9bfa2d7c8372f363fd5cebb4"
      ],
      "confidence": 0.9,
      "evidence": "pretreatment with flumazenil",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "benzodiazepine binding site of the GABA-A receptor",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "1a0f027a9bfa2d7c8372f363fd5cebb4"
      ],
      "confidence": 0.85,
      "evidence": "antagonist of the benzodiazepine binding site",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Compound",
      "name": "diazepam",
      "attributes": {},
      "source_chunk_ids": [
        "1a0f027a9bfa2d7c8372f363fd5cebb4"
      ],
      "confidence": 0.9,
      "evidence": "rats trained to discriminate diazepam",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Compound",
      "name": "amphetamine",
      "attributes": {},
      "source_chunk_ids": [
        "1a0f027a9bfa2d7c8372f363fd5cebb4"
      ],
      "confidence": 0.9,
      "evidence": "treatment with amphetamine",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Cherry's group studies on PDE4 inhibition and cocaine",
      "attributes": {
        "design": "series of studies",
        "year": "2009, 1999, 2004"
      },
      "source_chunk_ids": [
        "eb5a7bdfd928436fff356fb03c4dcdaa"
      ],
      "confidence": 0.9,
      "evidence": "series of studies by Cherry's group",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vivo rodent studies",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "eb5a7bdfd928436fff356fb03c4dcdaa"
      ],
      "confidence": 0.85,
      "evidence": "studies in rodents",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {},
      "source_chunk_ids": [
        "eb5a7bdfd928436fff356fb03c4dcdaa"
      ],
      "confidence": 0.95,
      "evidence": "selective PDE4 inhibitor rolipram",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "eb5a7bdfd928436fff356fb03c4dcdaa"
      ],
      "confidence": 0.9,
      "evidence": "PDE4 inhibition",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "cocaine reward",
      "attributes": {
        "condition_type": "behavioral"
      },
      "source_chunk_ids": [
        "eb5a7bdfd928436fff356fb03c4dcdaa"
      ],
      "confidence": 0.85,
      "evidence": "cocaine reward",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "incentive saliency",
      "attributes": {
        "condition_type": "behavioral"
      },
      "source_chunk_ids": [
        "eb5a7bdfd928436fff356fb03c4dcdaa"
      ],
      "confidence": 0.8,
      "evidence": "incentive saliency",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Condition",
      "name": "cocaine seeking",
      "attributes": {
        "condition_type": "behavioral"
      },
      "source_chunk_ids": [
        "eb5a7bdfd928436fff356fb03c4dcdaa"
      ],
      "confidence": 0.8,
      "evidence": "seeking in rodents",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Condition",
      "name": "cocaine-induced hyperlocomotor activity",
      "attributes": {
        "condition_type": "behavioral"
      },
      "source_chunk_ids": [
        "eb5a7bdfd928436fff356fb03c4dcdaa"
      ],
      "confidence": 0.85,
      "evidence": "cocaine-induced hyperlocomotor activity",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Condition",
      "name": "behavioral sensitization to cocaine",
      "attributes": {
        "condition_type": "behavioral"
      },
      "source_chunk_ids": [
        "eb5a7bdfd928436fff356fb03c4dcdaa"
      ],
      "confidence": 0.85,
      "evidence": "behavioral sensitization to cocaine",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "reduction in cocaine-induced hyperlocomotor activity",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "eb5a7bdfd928436fff356fb03c4dcdaa"
      ],
      "confidence": 0.8,
      "evidence": "greatly reduced cocaine-induced hyperlocomotor activity",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Effect",
      "name": "reduction in locomotor response to cocaine challenge",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "eb5a7bdfd928436fff356fb03c4dcdaa"
      ],
      "confidence": 0.75,
      "evidence": "reduced the locomotor response to a challenge dose",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Effect",
      "name": "reduction in expression of behavioral sensitization",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "eb5a7bdfd928436fff356fb03c4dcdaa"
      ],
      "confidence": 0.7,
      "evidence": "reduce expression of behavioral sensitization",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {},
      "source_chunk_ids": [
        "fb39eb6890494fdcaa8c73d29e6a18a3"
      ],
      "confidence": 0.95,
      "evidence": "Administration of rolipram",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {},
      "source_chunk_ids": [
        "fb39eb6890494fdcaa8c73d29e6a18a3"
      ],
      "confidence": 0.95,
      "evidence": "cocaine injection",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Effect",
      "name": "increase in locomotor activity",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "fb39eb6890494fdcaa8c73d29e6a18a3"
      ],
      "confidence": 0.85,
      "evidence": "cocaine-induced increase in locomotor activity",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "locomotor sensitization",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "fb39eb6890494fdcaa8c73d29e6a18a3"
      ],
      "confidence": 0.85,
      "evidence": "locomotor sensitization",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "fb39eb6890494fdcaa8c73d29e6a18a3"
      ],
      "confidence": 0.9,
      "evidence": "PDE4 inhibition",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Study",
      "name": "Janes et al., 2009",
      "attributes": {
        "year": 2009
      },
      "source_chunk_ids": [
        "fb39eb6890494fdcaa8c73d29e6a18a3"
      ],
      "confidence": 0.9,
      "evidence": "Janes et al., 2009",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Evidence",
      "name": "in vivo study",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "fb39eb6890494fdcaa8c73d29e6a18a3"
      ],
      "confidence": 0.8,
      "evidence": "Administration of rolipram",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Compound",
      "name": "isobutylmethylxanthine",
      "attributes": {},
      "source_chunk_ids": [
        "fb39eb6890494fdcaa8c73d29e6a18a3"
      ],
      "confidence": 0.95,
      "evidence": "isobutylmethylxanthine (IBMX)",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "PDE",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "fb39eb6890494fdcaa8c73d29e6a18a3"
      ],
      "confidence": 0.85,
      "evidence": "PDE inhibitor",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "acute hyperlocomotor response",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "fb39eb6890494fdcaa8c73d29e6a18a3"
      ],
      "confidence": 0.85,
      "evidence": "acute hyperlocomotor response to cocaine",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Effect",
      "name": "behavioral sensitization",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "fb39eb6890494fdcaa8c73d29e6a18a3"
      ],
      "confidence": 0.85,
      "evidence": "behavioral sensitization",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Study",
      "name": "Schroeder et al., 2012",
      "attributes": {
        "year": 2012
      },
      "source_chunk_ids": [
        "fb39eb6890494fdcaa8c73d29e6a18a3"
      ],
      "confidence": 0.9,
      "evidence": "Schroeder et al., 2012",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Evidence",
      "name": "in vivo study",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "fb39eb6890494fdcaa8c73d29e6a18a3"
      ],
      "confidence": 0.8,
      "evidence": "intracerebroventricular injection",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "2ef34a1ed1be70250b108ff951406441"
      ],
      "confidence": 0.9,
      "evidence": "PDE4 inhibitors",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Effect",
      "name": "enhance cognitive functions",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "2ef34a1ed1be70250b108ff951406441"
      ],
      "confidence": 0.85,
      "evidence": "enhance cognitive functions",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Effect",
      "name": "learning",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "2ef34a1ed1be70250b108ff951406441"
      ],
      "confidence": 0.8,
      "evidence": "learning and memory",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "memory",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "2ef34a1ed1be70250b108ff951406441"
      ],
      "confidence": 0.8,
      "evidence": "learning and memory",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "cognitive decline",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "2ef34a1ed1be70250b108ff951406441"
      ],
      "confidence": 0.9,
      "evidence": "cognitive decline",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "438eaeeff2ddb78e0179c22025e30a45"
      ],
      "confidence": 0.9,
      "evidence": "PDE4 inhibitor rolipram",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {},
      "source_chunk_ids": [
        "438eaeeff2ddb78e0179c22025e30a45"
      ],
      "confidence": 0.95,
      "evidence": "PDE4 inhibitor rolipram",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Study",
      "name": "Thompson et al., 2004",
      "attributes": {
        "year": 2004
      },
      "source_chunk_ids": [
        "438eaeeff2ddb78e0179c22025e30a45"
      ],
      "confidence": 0.85,
      "evidence": "Thompson et al., 2004",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Evidence",
      "name": "in vivo study",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "438eaeeff2ddb78e0179c22025e30a45"
      ],
      "confidence": 0.8,
      "evidence": "Systemic injections of rolipram",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "attenuates acquisition of cocaine CPP",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "438eaeeff2ddb78e0179c22025e30a45"
      ],
      "confidence": 0.85,
      "evidence": "rolipram attenuates the acquisition of CPP to cocaine",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "no effect on expression of cocaine CPP",
      "attributes": {
        "level": "behavioral",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "438eaeeff2ddb78e0179c22025e30a45"
      ],
      "confidence": 0.8,
      "evidence": "does not alter a previously established place preference",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "no place aversion or general memory impairment",
      "attributes": {
        "level": "behavioral",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "438eaeeff2ddb78e0179c22025e30a45"
      ],
      "confidence": 0.75,
      "evidence": "does not produce place aversion or impairment",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Condition",
      "name": "drug-cue associative memories",
      "attributes": {
        "condition_type": "cognitive"
      },
      "source_chunk_ids": [
        "438eaeeff2ddb78e0179c22025e30a45"
      ],
      "confidence": 0.7,
      "evidence": "dampen formation of drug-cue associative memories",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Bardo and Bevins, 2000",
      "attributes": {},
      "source_chunk_ids": [
        "d4c4e0812d48aeb817361c3603c67985"
      ],
      "confidence": 0.7,
      "evidence": "Bardo and Bevins, 2000",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Study",
      "name": "Todd et al., 2014",
      "attributes": {},
      "source_chunk_ids": [
        "d4c4e0812d48aeb817361c3603c67985"
      ],
      "confidence": 0.7,
      "evidence": "Todd et al., 2014",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Study",
      "name": "Itzhak and Anderson, 2012",
      "attributes": {},
      "source_chunk_ids": [
        "d4c4e0812d48aeb817361c3603c67985"
      ],
      "confidence": 0.8,
      "evidence": "Itzhak and Anderson, 2012",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Study",
      "name": "Liddie et al., 2012",
      "attributes": {},
      "source_chunk_ids": [
        "d4c4e0812d48aeb817361c3603c67985"
      ],
      "confidence": 0.8,
      "evidence": "Liddie et al., 2012",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Compound",
      "name": "BAY-73-6691",
      "attributes": {},
      "source_chunk_ids": [
        "d4c4e0812d48aeb817361c3603c67985"
      ],
      "confidence": 0.9,
      "evidence": "BAY-73-6691",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {},
      "source_chunk_ids": [
        "d4c4e0812d48aeb817361c3603c67985"
      ],
      "confidence": 0.9,
      "evidence": "rolipram",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "PDE9",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "d4c4e0812d48aeb817361c3603c67985"
      ],
      "confidence": 0.85,
      "evidence": "PDE9 (cGMP specific)",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "d4c4e0812d48aeb817361c3603c67985"
      ],
      "confidence": 0.85,
      "evidence": "PDE4 (cAMP specific)",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "facilitated extinction",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "d4c4e0812d48aeb817361c3603c67985"
      ],
      "confidence": 0.8,
      "evidence": "facilitated extinction",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "reduced cocaine primed reinstatement",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "d4c4e0812d48aeb817361c3603c67985"
      ],
      "confidence": 0.8,
      "evidence": "reduced cocaine primed reinstatement",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Effect",
      "name": "no significant effect on extinction",
      "attributes": {
        "level": "behavioral",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "d4c4e0812d48aeb817361c3603c67985"
      ],
      "confidence": 0.75,
      "evidence": "did not have a significant effect",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Condition",
      "name": "drug seeking behavior",
      "attributes": {
        "condition_type": "behavioral"
      },
      "source_chunk_ids": [
        "d4c4e0812d48aeb817361c3603c67985"
      ],
      "confidence": 0.85,
      "evidence": "drug seeking behavior",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Evidence",
      "name": "in vivo study",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "d4c4e0812d48aeb817361c3603c67985"
      ],
      "confidence": 0.7,
      "evidence": "mice were conditioned",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Knapp et al., 1999",
      "attributes": {
        "year": 1999
      },
      "source_chunk_ids": [
        "36b1c3f2221deeabc9cdc5585517b080"
      ],
      "confidence": 0.95,
      "evidence": "Knapp et al., 1999",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "animal study",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "36b1c3f2221deeabc9cdc5585517b080"
      ],
      "confidence": 0.85,
      "evidence": "In rats trained to self-administer cocaine",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {},
      "source_chunk_ids": [
        "36b1c3f2221deeabc9cdc5585517b080"
      ],
      "confidence": 0.9,
      "evidence": "systemic administration of either rolipram",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Compound",
      "name": "Ro 20-1724",
      "attributes": {},
      "source_chunk_ids": [
        "36b1c3f2221deeabc9cdc5585517b080"
      ],
      "confidence": 0.9,
      "evidence": "or Ro 20-1724",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "cocaine intake",
      "attributes": {
        "condition_type": "behavioral"
      },
      "source_chunk_ids": [
        "36b1c3f2221deeabc9cdc5585517b080"
      ],
      "confidence": 0.85,
      "evidence": "reduction in cocaine intake",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "reduction in motivated behavior",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "36b1c3f2221deeabc9cdc5585517b080"
      ],
      "confidence": 0.8,
      "evidence": "general effect on inhibiting motivated behavior",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "sedative effects",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "36b1c3f2221deeabc9cdc5585517b080"
      ],
      "confidence": 0.75,
      "evidence": "PDE4 inhibitors can have sedative effects",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "36b1c3f2221deeabc9cdc5585517b080"
      ],
      "confidence": 0.8,
      "evidence": "PDE4 inhibitors",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "ibudilast",
      "attributes": {},
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ],
      "confidence": 0.95,
      "evidence": "ibudilast",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Compound",
      "name": "AV1013",
      "attributes": {},
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ],
      "confidence": 0.95,
      "evidence": "AV1013",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "PDE",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ],
      "confidence": 0.9,
      "evidence": "non-selective PDE inhibitor",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "glial proinflammatory activity",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ],
      "confidence": 0.85,
      "evidence": "glial proinflammatory activity",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "reduced methamphetamine-induced locomotor activity",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ],
      "confidence": 0.8,
      "evidence": "reduce the methamphetamine-induced increase in locomotor activity",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "reduced methamphetamine self-administration",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ],
      "confidence": 0.8,
      "evidence": "reduces methamphetamine self-administration",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "reduced methamphetamine-seeking reinstatement",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ],
      "confidence": 0.8,
      "evidence": "reduces footshock- and prime-induced reinstatement of methamphetamine-seeking",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Study",
      "name": "Snider et al., 2012",
      "attributes": {
        "year": 2012
      },
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ],
      "confidence": 0.9,
      "evidence": "Snider et al., 2012",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Study",
      "name": "Snider et al., 2013",
      "attributes": {
        "year": 2013
      },
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ],
      "confidence": 0.9,
      "evidence": "Snider et al., 2013",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Study",
      "name": "Beardsley et al., 2010",
      "attributes": {
        "year": 2010
      },
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ],
      "confidence": 0.9,
      "evidence": "Beardsley et al., 2010",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Evidence",
      "name": "in vivo animal study",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ],
      "confidence": 0.85,
      "evidence": "in the rat",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "AV1013",
      "attributes": {},
      "source_chunk_ids": [
        "d715fd883cc9d85eb2d357cb456f6fa8"
      ],
      "confidence": 0.95,
      "evidence": "AV1013 shares the anti-inflammatory activity",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Compound",
      "name": "ibudilast",
      "attributes": {},
      "source_chunk_ids": [
        "d715fd883cc9d85eb2d357cb456f6fa8"
      ],
      "confidence": 0.95,
      "evidence": "anti-inflammatory activity of ibudilast",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Effect",
      "name": "anti-inflammatory activity",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "d715fd883cc9d85eb2d357cb456f6fa8"
      ],
      "confidence": 0.9,
      "evidence": "anti-inflammatory activity",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "PDE",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "d715fd883cc9d85eb2d357cb456f6fa8"
      ],
      "confidence": 0.85,
      "evidence": "inhibits PDE",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Study",
      "name": "Snider et al., 2012",
      "attributes": {
        "year": 2012
      },
      "source_chunk_ids": [
        "d715fd883cc9d85eb2d357cb456f6fa8"
      ],
      "confidence": 0.9,
      "evidence": "Snider et al., 2012",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "d715fd883cc9d85eb2d357cb456f6fa8"
      ],
      "confidence": 0.7,
      "evidence": "inhibits PDE",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "glial inflammatory activity",
      "attributes": {
        "target_type": "cellular process"
      },
      "source_chunk_ids": [
        "d715fd883cc9d85eb2d357cb456f6fa8"
      ],
      "confidence": 0.85,
      "evidence": "modulation of glial inflammatory activity",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Condition",
      "name": "methamphetamine abuse",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "d715fd883cc9d85eb2d357cb456f6fa8"
      ],
      "confidence": 0.9,
      "evidence": "treating methamphetamine abuse",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "attenuation of methamphetamine-induced locomotor sensitization",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "d715fd883cc9d85eb2d357cb456f6fa8"
      ],
      "confidence": 0.8,
      "evidence": "attenuation of methamphetamine-induced locomotor sensitization",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "attenuation of relapse of drug seeking",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "d715fd883cc9d85eb2d357cb456f6fa8"
      ],
      "confidence": 0.8,
      "evidence": "relapse of drug seeking",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "methamphetamine",
      "attributes": {},
      "source_chunk_ids": [
        "ce95485b6ce17ab8aea002931eab6c7c"
      ],
      "confidence": 0.95,
      "evidence": "Methamphetamine",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {},
      "source_chunk_ids": [
        "ce95485b6ce17ab8aea002931eab6c7c"
      ],
      "confidence": 0.95,
      "evidence": "cocaine",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "dopamine levels",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "ce95485b6ce17ab8aea002931eab6c7c"
      ],
      "confidence": 0.9,
      "evidence": "increasing extracellular dopamine levels",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Study",
      "name": "Anderson and Pierce, 2005",
      "attributes": {
        "year": 2005
      },
      "source_chunk_ids": [
        "ce95485b6ce17ab8aea002931eab6c7c"
      ],
      "confidence": 0.85,
      "evidence": "Anderson and Pierce, 2005",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {},
      "source_chunk_ids": [
        "ce95485b6ce17ab8aea002931eab6c7c"
      ],
      "confidence": 0.95,
      "evidence": "rolipram",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "striatal cAMP levels",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "ce95485b6ce17ab8aea002931eab6c7c"
      ],
      "confidence": 0.85,
      "evidence": "increases striatal cAMP levels",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "striatal dopamine levels",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "ce95485b6ce17ab8aea002931eab6c7c"
      ],
      "confidence": 0.85,
      "evidence": "methamphetamine-induced increase in striatal dopamine levels",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Study",
      "name": "Iyo et al., 1996",
      "attributes": {
        "year": 1996
      },
      "source_chunk_ids": [
        "ce95485b6ce17ab8aea002931eab6c7c"
      ],
      "confidence": 0.85,
      "evidence": "Iyo et al., 1996",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Evidence",
      "name": "in vivo microdialysis",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "ce95485b6ce17ab8aea002931eab6c7c"
      ],
      "confidence": 0.8,
      "evidence": "In vivo microdialysis",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDEs",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "0bc25299772f1d7d19378a920b823f62"
      ],
      "confidence": 0.9,
      "evidence": "Regulation of alcohol drinking by many different subtypes of PDEs",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "0bc25299772f1d7d19378a920b823f62"
      ],
      "confidence": 0.85,
      "evidence": "behavioral effects of PDE4 inhibitors",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "alcohol drinking",
      "attributes": {
        "condition_type": "behavior"
      },
      "source_chunk_ids": [
        "0bc25299772f1d7d19378a920b823f62"
      ],
      "confidence": 0.95,
      "evidence": "Regulation of alcohol drinking",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Study",
      "name": "Logrip, 2015",
      "attributes": {
        "year": 2015
      },
      "source_chunk_ids": [
        "0bc25299772f1d7d19378a920b823f62"
      ],
      "confidence": 0.8,
      "evidence": "reviewed in great detail (Logrip, 2015)",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Evidence",
      "name": "review",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "0bc25299772f1d7d19378a920b823f62"
      ],
      "confidence": 0.75,
      "evidence": "reviewed in great detail",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "Rolipram",
      "attributes": {},
      "source_chunk_ids": [
        "9e438a2ab71427981a77ff504eca50bc"
      ],
      "confidence": 0.95,
      "evidence": "Rolipram and Ro 20-1724 reduce alcohol intake",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Compound",
      "name": "Ro 20-1724",
      "attributes": {},
      "source_chunk_ids": [
        "9e438a2ab71427981a77ff504eca50bc"
      ],
      "confidence": 0.95,
      "evidence": "Rolipram and Ro 20-1724 reduce alcohol intake",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "9e438a2ab71427981a77ff504eca50bc"
      ],
      "confidence": 0.9,
      "evidence": "Reduction of alcohol drinking by PDE4 inhibitors",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "reduction of alcohol drinking",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "9e438a2ab71427981a77ff504eca50bc"
      ],
      "confidence": 0.85,
      "evidence": "Reduction of alcohol drinking by PDE4 inhibitors",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "reduction of alcohol intake",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "9e438a2ab71427981a77ff504eca50bc"
      ],
      "confidence": 0.9,
      "evidence": "Rolipram and Ro 20-1724 reduce alcohol intake",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "reduction of alcohol preference",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "9e438a2ab71427981a77ff504eca50bc"
      ],
      "confidence": 0.9,
      "evidence": "Rolipram and Ro 20-1724 reduce alcohol intake and preference",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Study",
      "name": "Hu et al., 2011",
      "attributes": {
        "year": 2011
      },
      "source_chunk_ids": [
        "9e438a2ab71427981a77ff504eca50bc"
      ],
      "confidence": 0.8,
      "evidence": "Hu et al., 2011",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Study",
      "name": "Wen et al., 2012",
      "attributes": {
        "year": 2012
      },
      "source_chunk_ids": [
        "9e438a2ab71427981a77ff504eca50bc"
      ],
      "confidence": 0.8,
      "evidence": "Wen et al., 2012",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Evidence",
      "name": "in vivo animal study",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "9e438a2ab71427981a77ff504eca50bc"
      ],
      "confidence": 0.85,
      "evidence": "in C57BL/6J mice",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "ibudilast",
      "attributes": {},
      "source_chunk_ids": [
        "b4d61aa725cb159fe54c87b64295c5f8"
      ],
      "confidence": 0.95,
      "evidence": "ibudilast reduces 2-bottle choice alcohol drinking",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "PDE",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "b4d61aa725cb159fe54c87b64295c5f8"
      ],
      "confidence": 0.9,
      "evidence": "non-selective phosphodiesterase inhibitor",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "alcohol drinking",
      "attributes": {
        "condition_type": "behavior"
      },
      "source_chunk_ids": [
        "b4d61aa725cb159fe54c87b64295c5f8"
      ],
      "confidence": 0.9,
      "evidence": "reduces 2-bottle choice alcohol drinking",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "relapse",
      "attributes": {
        "condition_type": "behavior"
      },
      "source_chunk_ids": [
        "b4d61aa725cb159fe54c87b64295c5f8"
      ],
      "confidence": 0.85,
      "evidence": "reduces 2-bottle choice alcohol drinking and relapse",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Study",
      "name": "Bell et al., 2015",
      "attributes": {
        "year": 2015
      },
      "source_chunk_ids": [
        "b4d61aa725cb159fe54c87b64295c5f8"
      ],
      "confidence": 0.9,
      "evidence": "Bell et al., 2015",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Evidence",
      "name": "animal study",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "b4d61aa725cb159fe54c87b64295c5f8"
      ],
      "confidence": 0.8,
      "evidence": "rodent models",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "b4d61aa725cb159fe54c87b64295c5f8"
      ],
      "confidence": 0.9,
      "evidence": "selective PDE4 inhibitors reduce ethanol intake",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "PDE10A",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "b4d61aa725cb159fe54c87b64295c5f8"
      ],
      "confidence": 0.9,
      "evidence": "PDE10A inhibitor TP-10 reduces alcohol self-administration",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Compound",
      "name": "TP-10",
      "attributes": {},
      "source_chunk_ids": [
        "b4d61aa725cb159fe54c87b64295c5f8"
      ],
      "confidence": 0.95,
      "evidence": "PDE10A inhibitor TP-10",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Study",
      "name": "Blednov et al., 2014",
      "attributes": {
        "year": 2014
      },
      "source_chunk_ids": [
        "b4d61aa725cb159fe54c87b64295c5f8"
      ],
      "confidence": 0.9,
      "evidence": "Blednov et al., 2014",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Study",
      "name": "Logrip et al., 2014",
      "attributes": {
        "year": 2014
      },
      "source_chunk_ids": [
        "b4d61aa725cb159fe54c87b64295c5f8"
      ],
      "confidence": 0.9,
      "evidence": "Logrip et al., 2014",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Condition",
      "name": "alcohol dependence",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "b4d61aa725cb159fe54c87b64295c5f8"
      ],
      "confidence": 0.9,
      "evidence": "potential therapeutic targets for pharmacotherapy of alcohol dependence",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Effect",
      "name": "reduces alcohol drinking",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "b4d61aa725cb159fe54c87b64295c5f8"
      ],
      "confidence": 0.85,
      "evidence": "PDE inhibitors reduce alcohol drinking",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {},
      "source_chunk_ids": [
        "b89d713905ece27bb27ff3436679ae21"
      ],
      "confidence": 0.95,
      "evidence": "rolipram suppresses morphine-induced hyperlocomotion",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Compound",
      "name": "morphine",
      "attributes": {},
      "source_chunk_ids": [
        "b89d713905ece27bb27ff3436679ae21"
      ],
      "confidence": 0.95,
      "evidence": "morphine-induced hyperlocomotor activity",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "b89d713905ece27bb27ff3436679ae21"
      ],
      "confidence": 0.9,
      "evidence": "PDE4 inhibitors reduce morphine-induced hyperlocomotor activity",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "reduced hyperlocomotor activity",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "b89d713905ece27bb27ff3436679ae21"
      ],
      "confidence": 0.85,
      "evidence": "reduces morphine-induced hyperlocomotor activity",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "blocked acquisition of conditioned place preference",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "b89d713905ece27bb27ff3436679ae21"
      ],
      "confidence": 0.85,
      "evidence": "blocks the acquisition of CPP to morphine",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "inhibited discriminative-stimulus effects",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "b89d713905ece27bb27ff3436679ae21"
      ],
      "confidence": 0.85,
      "evidence": "inhibits the discriminative-stimulus effects of morphine",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "cAMP signaling cascade",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "b89d713905ece27bb27ff3436679ae21"
      ],
      "confidence": 0.8,
      "evidence": "cAMP signaling cascade may play a key role",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Study",
      "name": "Mori et al., 2000",
      "attributes": {
        "year": 2000
      },
      "source_chunk_ids": [
        "b89d713905ece27bb27ff3436679ae21"
      ],
      "confidence": 0.9,
      "evidence": "Mori et al., 2000",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Study",
      "name": "Thompson et al., 2004",
      "attributes": {
        "year": 2004
      },
      "source_chunk_ids": [
        "b89d713905ece27bb27ff3436679ae21"
      ],
      "confidence": 0.9,
      "evidence": "Thompson et al., 2004",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Study",
      "name": "Yan et al., 2006",
      "attributes": {
        "year": 2006
      },
      "source_chunk_ids": [
        "b89d713905ece27bb27ff3436679ae21"
      ],
      "confidence": 0.9,
      "evidence": "Yan et al., 2006",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Evidence",
      "name": "in vivo animal study",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "b89d713905ece27bb27ff3436679ae21"
      ],
      "confidence": 0.85,
      "evidence": "systemic injections of rolipram",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {},
      "source_chunk_ids": [
        "53b94c741b1bf38dd8ab9587398b6fc0"
      ],
      "confidence": 0.95,
      "evidence": "rolipram",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "53b94c741b1bf38dd8ab9587398b6fc0"
      ],
      "confidence": 0.9,
      "evidence": "PDE4 inhibitor",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Effect",
      "name": "decreases heroin self-administration reward values",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "53b94c741b1bf38dd8ab9587398b6fc0"
      ],
      "confidence": 0.85,
      "evidence": "dose-dependently decreases the reward values",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "decreases reinstatement of heroin seeking",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "53b94c741b1bf38dd8ab9587398b6fc0"
      ],
      "confidence": 0.9,
      "evidence": "decreases the cue- and heroin priming-induced reinstatement",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "increases phosphorylated CREB expression",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "53b94c741b1bf38dd8ab9587398b6fc0"
      ],
      "confidence": 0.85,
      "evidence": "increases the expression of phosphorylated CREB",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "phosphorylated CREB",
      "attributes": {
        "target_type": "protein"
      },
      "source_chunk_ids": [
        "53b94c741b1bf38dd8ab9587398b6fc0"
      ],
      "confidence": 0.8,
      "evidence": "phosphorylated CREB",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Condition",
      "name": "heroin dependence",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "53b94c741b1bf38dd8ab9587398b6fc0"
      ],
      "confidence": 0.9,
      "evidence": "heroin dependence",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Condition",
      "name": "morphine dependence",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "53b94c741b1bf38dd8ab9587398b6fc0"
      ],
      "confidence": 0.9,
      "evidence": "morphine dependence",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Study",
      "name": "Lai et al., 2014",
      "attributes": {
        "year": 2014
      },
      "source_chunk_ids": [
        "53b94c741b1bf38dd8ab9587398b6fc0"
      ],
      "confidence": 0.95,
      "evidence": "Lai et al., 2014",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Evidence",
      "name": "in vivo study",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "53b94c741b1bf38dd8ab9587398b6fc0"
      ],
      "confidence": 0.8,
      "evidence": "heroin self-administration",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "9eb6f4d54e0030fe9bdf47faf190909e"
      ],
      "confidence": 0.95,
      "evidence": "PDE4 inhibitors",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "morphine withdrawal symptoms",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "9eb6f4d54e0030fe9bdf47faf190909e"
      ],
      "confidence": 0.9,
      "evidence": "naloxone-precipitated morphine withdrawal symptoms",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Study",
      "name": "Kimura et al., 2006",
      "attributes": {
        "year": 2006
      },
      "source_chunk_ids": [
        "9eb6f4d54e0030fe9bdf47faf190909e"
      ],
      "confidence": 0.85,
      "evidence": "Kimura et al., 2006",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "9eb6f4d54e0030fe9bdf47faf190909e"
      ],
      "confidence": 0.8,
      "evidence": "in rats",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Study",
      "name": "Gonzalez-Cuello et al., 2007",
      "attributes": {
        "year": 2007
      },
      "source_chunk_ids": [
        "9eb6f4d54e0030fe9bdf47faf190909e"
      ],
      "confidence": 0.85,
      "evidence": "Gonzalez-Cuello et al., 2007",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Study",
      "name": "Hamdy et al., 2001",
      "attributes": {
        "year": 2001
      },
      "source_chunk_ids": [
        "9eb6f4d54e0030fe9bdf47faf190909e"
      ],
      "confidence": 0.85,
      "evidence": "Hamdy et al., 2001",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Study",
      "name": "Mamiya et al., 2001",
      "attributes": {
        "year": 2001
      },
      "source_chunk_ids": [
        "9eb6f4d54e0030fe9bdf47faf190909e"
      ],
      "confidence": 0.85,
      "evidence": "Mamiya et al., 2001",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Study",
      "name": "Nunez et al., 2009",
      "attributes": {
        "year": 2009
      },
      "source_chunk_ids": [
        "9eb6f4d54e0030fe9bdf47faf190909e"
      ],
      "confidence": 0.85,
      "evidence": "Nunez et al., 2009",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {},
      "source_chunk_ids": [
        "9eb6f4d54e0030fe9bdf47faf190909e"
      ],
      "confidence": 0.9,
      "evidence": "PDE4 inhibitors rolipram",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "attenuation of withdrawal syndrome",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "9eb6f4d54e0030fe9bdf47faf190909e"
      ],
      "confidence": 0.85,
      "evidence": "attenuation of withdrawal syndrome",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Target",
      "name": "cAMP signaling",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "9eb6f4d54e0030fe9bdf47faf190909e"
      ],
      "confidence": 0.8,
      "evidence": "cAMP signaling",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Target",
      "name": "c-Fos protein",
      "attributes": {
        "target_type": "protein"
      },
      "source_chunk_ids": [
        "9eb6f4d54e0030fe9bdf47faf190909e"
      ],
      "confidence": 0.8,
      "evidence": "c-Fos protein",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Effect",
      "name": "increase in cAMP levels",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "9eb6f4d54e0030fe9bdf47faf190909e"
      ],
      "confidence": 0.75,
      "evidence": "increase in levels of cAMP",
      "verified": true
    },
    {
      "id": "E1",
      "type": "CompoundClass",
      "name": "PDE4 inhibitors",
      "attributes": {},
      "source_chunk_ids": [
        "80f190250acd8f566c4344404c65092c"
      ],
      "confidence": 0.95,
      "evidence": "PDE4 inhibitors reduce opioid-induced respiratory depression",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "opioid-induced respiratory depression",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "80f190250acd8f566c4344404c65092c"
      ],
      "confidence": 0.9,
      "evidence": "opioid-induced respiratory depression",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Study",
      "name": "Kimura et al., 2015",
      "attributes": {
        "year": 2015
      },
      "source_chunk_ids": [
        "80f190250acd8f566c4344404c65092c"
      ],
      "confidence": 0.85,
      "evidence": "Kimura et al., 2015",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Evidence",
      "name": "animal study",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "80f190250acd8f566c4344404c65092c"
      ],
      "confidence": 0.8,
      "evidence": "In rats, intravenous injection of rolipram",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {},
      "source_chunk_ids": [
        "80f190250acd8f566c4344404c65092c"
      ],
      "confidence": 0.9,
      "evidence": "intravenous injection of rolipram",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Compound",
      "name": "morphine",
      "attributes": {},
      "source_chunk_ids": [
        "80f190250acd8f566c4344404c65092c"
      ],
      "confidence": 0.9,
      "evidence": "morphine-induced prolongation",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "ventilatory depression",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "80f190250acd8f566c4344404c65092c"
      ],
      "confidence": 0.85,
      "evidence": "morphine-induced ventilatory depression",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "analgesia",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "80f190250acd8f566c4344404c65092c"
      ],
      "confidence": 0.85,
      "evidence": "without loss of analgesia",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "80f190250acd8f566c4344404c65092c"
      ],
      "confidence": 0.9,
      "evidence": "inhibition of PDE4",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "c-Fos",
      "attributes": {
        "target_type": "transcription factor"
      },
      "source_chunk_ids": [
        "a812b8d01d3567df5b0b6d3914f3c92c"
      ],
      "confidence": 0.9,
      "evidence": "c-Fos is part of the AP-1 transcription complex",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "AP-1 transcription complex",
      "attributes": {
        "target_type": "transcription complex"
      },
      "source_chunk_ids": [
        "a812b8d01d3567df5b0b6d3914f3c92c"
      ],
      "confidence": 0.85,
      "evidence": "c-Fos is part of the AP-1 transcription complex",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Effect",
      "name": "activation of signaling cascades",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "a812b8d01d3567df5b0b6d3914f3c92c"
      ],
      "confidence": 0.8,
      "evidence": "results in activation of signaling cascades",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "synaptic and behavioral plasticity",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "a812b8d01d3567df5b0b6d3914f3c92c"
      ],
      "confidence": 0.75,
      "evidence": "important in synaptic and behavioral plasticity",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {},
      "source_chunk_ids": [
        "a812b8d01d3567df5b0b6d3914f3c92c"
      ],
      "confidence": 0.95,
      "evidence": "rolipram has no effect on cocaine-induced expression",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {},
      "source_chunk_ids": [
        "a812b8d01d3567df5b0b6d3914f3c92c"
      ],
      "confidence": 0.9,
      "evidence": "cocaine-induced expression of c-Fos",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "cocaine-induced expression of c-Fos",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "a812b8d01d3567df5b0b6d3914f3c92c"
      ],
      "confidence": 0.8,
      "evidence": "cocaine-induced expression of c-Fos",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "increased c-Fos levels in nucleus accumbens shell",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "a812b8d01d3567df5b0b6d3914f3c92c"
      ],
      "confidence": 0.75,
      "evidence": "rolipram itself increases levels in the nucleus accumbens shell",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Study",
      "name": "Thompson et al., 2004",
      "attributes": {
        "year": 2004
      },
      "source_chunk_ids": [
        "a812b8d01d3567df5b0b6d3914f3c92c"
      ],
      "confidence": 0.85,
      "evidence": "Thompson et al., 2004",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Evidence",
      "name": "in vivo study",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "a812b8d01d3567df5b0b6d3914f3c92c"
      ],
      "confidence": 0.7,
      "evidence": "Within the dorsal striatum and nucleus accumbens",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE activity in the nucleus accumbens",
      "attributes": {
        "target_type": "enzyme activity"
      },
      "source_chunk_ids": [
        "c6daedd4d0f94e8bf3c21d0b937492eb"
      ],
      "confidence": 0.85,
      "evidence": "PDE activity in the nucleus accumbens",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Effect",
      "name": "modulate the reinforcing effect of intracranial self-stimulation of the VTA",
      "attributes": {
        "level": "behavioral",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "c6daedd4d0f94e8bf3c21d0b937492eb"
      ],
      "confidence": 0.8,
      "evidence": "modulate the reinforcing effect of intracranial self-stimulation",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {},
      "source_chunk_ids": [
        "c6daedd4d0f94e8bf3c21d0b937492eb"
      ],
      "confidence": 0.9,
      "evidence": "Infusion of rolipram",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "decreases the threshold of intracranial self-stimulation",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "c6daedd4d0f94e8bf3c21d0b937492eb"
      ],
      "confidence": 0.85,
      "evidence": "decreases the threshold of intracranial self-stimulation",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {},
      "source_chunk_ids": [
        "c6daedd4d0f94e8bf3c21d0b937492eb"
      ],
      "confidence": 0.9,
      "evidence": "systemic cocaine",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "enhances the effects of systemic cocaine on lowering the threshold of intracranial self-stimulation",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "c6daedd4d0f94e8bf3c21d0b937492eb"
      ],
      "confidence": 0.8,
      "evidence": "enhances the effects of systemic cocaine",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Study",
      "name": "Knapp et al., 2001",
      "attributes": {
        "year": 2001
      },
      "source_chunk_ids": [
        "c6daedd4d0f94e8bf3c21d0b937492eb"
      ],
      "confidence": 0.95,
      "evidence": "Knapp et al., 2001",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Evidence",
      "name": "in vivo study",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "c6daedd4d0f94e8bf3c21d0b937492eb"
      ],
      "confidence": 0.75,
      "evidence": "Infusion of rolipram into the nucleus accumbens",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "cyclic AMP (cAMP) pathways within the nucleus accumbens",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "c6daedd4d0f94e8bf3c21d0b937492eb"
      ],
      "confidence": 0.85,
      "evidence": "cyclic AMP (cAMP) pathways within the nucleus accumbens",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "enhance general brain reward function",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "c6daedd4d0f94e8bf3c21d0b937492eb"
      ],
      "confidence": 0.8,
      "evidence": "enhance general brain reward function",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Condition",
      "name": "incubation of craving",
      "attributes": {
        "condition_type": "phenomenon"
      },
      "source_chunk_ids": [
        "7fe5167426c0f3fa249523c61eea8303"
      ],
      "confidence": 0.95,
      "evidence": "Incubation of craving is a phenomenon",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "heroin craving",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "7fe5167426c0f3fa249523c61eea8303"
      ],
      "confidence": 0.9,
      "evidence": "Incubation of heroin craving",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "pCREB",
      "attributes": {
        "target_type": "protein"
      },
      "source_chunk_ids": [
        "7fe5167426c0f3fa249523c61eea8303"
      ],
      "confidence": 0.85,
      "evidence": "decreased phosphorylated CREB (pCREB)",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "nucleus accumbens",
      "attributes": {
        "target_type": "brain_region"
      },
      "source_chunk_ids": [
        "7fe5167426c0f3fa249523c61eea8303"
      ],
      "confidence": 0.9,
      "evidence": "in the nucleus accumbens",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {},
      "source_chunk_ids": [
        "7fe5167426c0f3fa249523c61eea8303"
      ],
      "confidence": 0.95,
      "evidence": "intra-accumbens rolipram",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "reduced drug seeking",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "7fe5167426c0f3fa249523c61eea8303"
      ],
      "confidence": 0.85,
      "evidence": "rolipram reduced drug seeking",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "increased pCREB levels",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "7fe5167426c0f3fa249523c61eea8303"
      ],
      "confidence": 0.85,
      "evidence": "increased local pCREB levels",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Study",
      "name": "Sun et al., 2015",
      "attributes": {
        "year": 2015
      },
      "source_chunk_ids": [
        "7fe5167426c0f3fa249523c61eea8303"
      ],
      "confidence": 0.9,
      "evidence": "Sun et al., 2015",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Evidence",
      "name": "in vivo study",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "7fe5167426c0f3fa249523c61eea8303"
      ],
      "confidence": 0.8,
      "evidence": "intra-accumbens rolipram",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Zhong et al., 2012",
      "attributes": {
        "year": 2012
      },
      "source_chunk_ids": [
        "bffa1ced7228afd9a051ecf8de97e02d"
      ],
      "confidence": 0.9,
      "evidence": "Zhong et al., 2012",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vivo study",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "bffa1ced7228afd9a051ecf8de97e02d"
      ],
      "confidence": 0.8,
      "evidence": "intra-VTA injection",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {},
      "source_chunk_ids": [
        "bffa1ced7228afd9a051ecf8de97e02d"
      ],
      "confidence": 0.95,
      "evidence": "rolipram",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "bffa1ced7228afd9a051ecf8de97e02d"
      ],
      "confidence": 0.9,
      "evidence": "PDE4 inhibition",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "blocked acquisition of cocaine CPP",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "bffa1ced7228afd9a051ecf8de97e02d"
      ],
      "confidence": 0.85,
      "evidence": "blocked the acquisition of cocaine CPP",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "did not affect expression of cocaine CPP",
      "attributes": {
        "level": "behavioral",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "bffa1ced7228afd9a051ecf8de97e02d"
      ],
      "confidence": 0.85,
      "evidence": "did not affect the expression of cocaine CPP",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Condition",
      "name": "cocaine CPP",
      "attributes": {
        "condition_type": "behavioral"
      },
      "source_chunk_ids": [
        "bffa1ced7228afd9a051ecf8de97e02d"
      ],
      "confidence": 0.8,
      "evidence": "cocaine CPP",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "long-term synaptic plasticity in reward circuitry",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "e479cb817091711ddd4d2c74e216604f"
      ],
      "confidence": 0.85,
      "evidence": "Long-term synaptic plasticity in reward circuitry",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "endocannabinoid-mediated long-term depression of inhibitory synaptic transmission (I-LTD)",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "e479cb817091711ddd4d2c74e216604f"
      ],
      "confidence": 0.9,
      "evidence": "endocannabinoid-mediated long-term depression of inhibitory synaptic transmission (I-LTD)",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "cocaine-induced inhibitory synaptic plasticity",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "e479cb817091711ddd4d2c74e216604f"
      ],
      "confidence": 0.9,
      "evidence": "cocaine-induced inhibitory synaptic plasticity",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "cannabinoid receptors (CB_1)",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "e479cb817091711ddd4d2c74e216604f"
      ],
      "confidence": 0.95,
      "evidence": "Cannabinoid receptors (CB_1)",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "adenylyl cyclase (AC)",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "e479cb817091711ddd4d2c74e216604f"
      ],
      "confidence": 0.9,
      "evidence": "adenylyl cyclase (AC)",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "cAMP/PKA activity",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "e479cb817091711ddd4d2c74e216604f"
      ],
      "confidence": 0.85,
      "evidence": "cAMP/PKA activity",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "e479cb817091711ddd4d2c74e216604f"
      ],
      "confidence": 0.9,
      "evidence": "PDE4 inhibition",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {},
      "source_chunk_ids": [
        "e479cb817091711ddd4d2c74e216604f"
      ],
      "confidence": 0.95,
      "evidence": "rolipram",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Compound",
      "name": "Ro 20-1724",
      "attributes": {},
      "source_chunk_ids": [
        "e479cb817091711ddd4d2c74e216604f"
      ],
      "confidence": 0.95,
      "evidence": "Ro 20-1724",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Target",
      "name": "D_2 dopamine receptor",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "e479cb817091711ddd4d2c74e216604f"
      ],
      "confidence": 0.9,
      "evidence": "D_2 dopamine receptor",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Target",
      "name": "VTA dopamine neurons",
      "attributes": {
        "target_type": "cellular"
      },
      "source_chunk_ids": [
        "e479cb817091711ddd4d2c74e216604f"
      ],
      "confidence": 0.85,
      "evidence": "VTA dopamine neurons",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Effect",
      "name": "blockade of cocaine-induced inhibitory synaptic plasticity",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "e479cb817091711ddd4d2c74e216604f"
      ],
      "confidence": 0.85,
      "evidence": "blockade of cocaine-induced inhibitory synaptic plasticity",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Effect",
      "name": "impairs CPP to cocaine",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "e479cb817091711ddd4d2c74e216604f"
      ],
      "confidence": 0.8,
      "evidence": "impairs CPP to cocaine",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Condition",
      "name": "addictive behavior",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "e479cb817091711ddd4d2c74e216604f"
      ],
      "confidence": 0.85,
      "evidence": "development of addictive behavior",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Study",
      "name": "Zhong et al., 2012",
      "attributes": {
        "year": 2012
      },
      "source_chunk_ids": [
        "e479cb817091711ddd4d2c74e216604f"
      ],
      "confidence": 0.9,
      "evidence": "Zhong et al., 2012",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "e479cb817091711ddd4d2c74e216604f"
      ],
      "confidence": 0.8,
      "evidence": "in VTA dopamine neurons",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "a066a69009569bacd4df52d66c844bee"
      ],
      "confidence": 0.95,
      "evidence": "isoforms and splice variants of PDE4",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "COPD",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "a066a69009569bacd4df52d66c844bee"
      ],
      "confidence": 0.9,
      "evidence": "treatment of COPD",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "inflammatory diseases",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "a066a69009569bacd4df52d66c844bee"
      ],
      "confidence": 0.9,
      "evidence": "treatment of COPD and inflammatory diseases",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "drug addiction",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "a066a69009569bacd4df52d66c844bee"
      ],
      "confidence": 0.95,
      "evidence": "pharmacological intervention of drug addiction",
      "verified": true
    },
    {
      "id": "E5",
      "type": "CompoundClass",
      "name": "PDE4 inhibitors",
      "attributes": {},
      "source_chunk_ids": [
        "a066a69009569bacd4df52d66c844bee"
      ],
      "confidence": 0.9,
      "evidence": "PDE4 inhibitors have been approved",
      "verified": true
    },
    {
      "id": "E1",
      "type": "CompoundClass",
      "name": "PDE4 inhibitors",
      "attributes": {},
      "source_chunk_ids": [
        "4b1724b03dc618f80a443b41b0133ca0"
      ],
      "confidence": 0.95,
      "evidence": "PDE4 inhibitors such as rolipram",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {},
      "source_chunk_ids": [
        "4b1724b03dc618f80a443b41b0133ca0"
      ],
      "confidence": 0.9,
      "evidence": "rolipram",
      "verified": true
    },
    {
      "id": "E3",
      "type": "AdverseEvent",
      "name": "nausea",
      "attributes": {},
      "source_chunk_ids": [
        "4b1724b03dc618f80a443b41b0133ca0"
      ],
      "confidence": 0.9,
      "evidence": "cause nausea",
      "verified": true
    },
    {
      "id": "E4",
      "type": "AdverseEvent",
      "name": "emesis",
      "attributes": {},
      "source_chunk_ids": [
        "4b1724b03dc618f80a443b41b0133ca0"
      ],
      "confidence": 0.9,
      "evidence": "cause emesis",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "4b1724b03dc618f80a443b41b0133ca0"
      ],
      "confidence": 0.85,
      "evidence": "PDE4 expressed in the area postrema",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "PDE4A",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "4b1724b03dc618f80a443b41b0133ca0"
      ],
      "confidence": 0.8,
      "evidence": "PDE4A is predominantly expressed",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "PDE4B",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "4b1724b03dc618f80a443b41b0133ca0"
      ],
      "confidence": 0.8,
      "evidence": "PDE4B is highly expressed",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Study",
      "name": "Hansen and Zhang, 2015",
      "attributes": {
        "year": 2015
      },
      "source_chunk_ids": [
        "4b1724b03dc618f80a443b41b0133ca0"
      ],
      "confidence": 0.7,
      "evidence": "Hansen and Zhang, 2015",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Study",
      "name": "Mori et al., 2010",
      "attributes": {
        "year": 2010
      },
      "source_chunk_ids": [
        "4b1724b03dc618f80a443b41b0133ca0"
      ],
      "confidence": 0.7,
      "evidence": "Mori et al., 2010",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "PDE4D",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "a5db36073075bb0ff21936c65889e93c"
      ],
      "confidence": 0.95,
      "evidence": "PDE4D is expressed in many parts of the brain",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "PDE4B",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "a5db36073075bb0ff21936c65889e93c"
      ],
      "confidence": 0.95,
      "evidence": "PDE4 inhibition-induced reduction may be mediated primarily by PDE4B",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Effect",
      "name": "reduction of drug seeking behavior",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "a5db36073075bb0ff21936c65889e93c"
      ],
      "confidence": 0.85,
      "evidence": "reduce drug seeking behavior",
      "verified": true
    },
    {
      "id": "E4",
      "type": "AdverseEvent",
      "name": "emesis",
      "attributes": {
        "severity": "not specified"
      },
      "source_chunk_ids": [
        "a5db36073075bb0ff21936c65889e93c"
      ],
      "confidence": 0.9,
      "evidence": "emetic effects of PDE4 inhibitors",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "anti-inflammatory effects",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "a5db36073075bb0ff21936c65889e93c"
      ],
      "confidence": 0.85,
      "evidence": "exhibited potent anti-inflammatory effects in vivo",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "generalized anxiety",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "a5db36073075bb0ff21936c65889e93c"
      ],
      "confidence": 0.9,
      "evidence": "PDE4B inhibition may also have effects on generalized anxiety",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Condition",
      "name": "drug craving",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "a5db36073075bb0ff21936c65889e93c"
      ],
      "confidence": 0.85,
      "evidence": "influence drug craving during abstinence",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "increased anxiety-like behavior",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "a5db36073075bb0ff21936c65889e93c"
      ],
      "confidence": 0.8,
      "evidence": "resulted in increased anxiety-like behavior",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "reduced anxiety-like behavior",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "a5db36073075bb0ff21936c65889e93c"
      ],
      "confidence": 0.8,
      "evidence": "reduced anxiety-like behavior",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Study",
      "name": "Cherry and Davis, 1999",
      "attributes": {
        "year": 1999
      },
      "source_chunk_ids": [
        "a5db36073075bb0ff21936c65889e93c"
      ],
      "confidence": 0.9,
      "evidence": "Cherry and Davis, 1999",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Study",
      "name": "Hagen et al., 2014",
      "attributes": {
        "year": 2014
      },
      "source_chunk_ids": [
        "a5db36073075bb0ff21936c65889e93c"
      ],
      "confidence": 0.9,
      "evidence": "Hagen et al., 2014",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Study",
      "name": "Naganuma et al., 2009",
      "attributes": {
        "year": 2009
      },
      "source_chunk_ids": [
        "a5db36073075bb0ff21936c65889e93c"
      ],
      "confidence": 0.9,
      "evidence": "Naganuma et al., 2009",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Study",
      "name": "Zhang et al., 2008",
      "attributes": {
        "year": 2008
      },
      "source_chunk_ids": [
        "a5db36073075bb0ff21936c65889e93c"
      ],
      "confidence": 0.9,
      "evidence": "Zhang et al., 2008",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Study",
      "name": "Siuciak et al., 2008",
      "attributes": {
        "year": 2008
      },
      "source_chunk_ids": [
        "a5db36073075bb0ff21936c65889e93c"
      ],
      "confidence": 0.9,
      "evidence": "Siuciak et al., 2008",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Study",
      "name": "McGirr et al., 2016",
      "attributes": {
        "year": 2016
      },
      "source_chunk_ids": [
        "a5db36073075bb0ff21936c65889e93c"
      ],
      "confidence": 0.9,
      "evidence": "McGirr et al., 2016",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "a5db36073075bb0ff21936c65889e93c"
      ],
      "confidence": 0.8,
      "evidence": "not explicitly stated, inferred from context",
      "verified": true
    },
    {
      "id": "E17",
      "type": "Evidence",
      "name": "in vivo",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "a5db36073075bb0ff21936c65889e93c"
      ],
      "confidence": 0.85,
      "evidence": "exhibited potent anti-inflammatory effects in vivo",
      "verified": true
    },
    {
      "id": "E18",
      "type": "Evidence",
      "name": "animal study",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "a5db36073075bb0ff21936c65889e93c"
      ],
      "confidence": 0.8,
      "evidence": "Knockout of a large region of the catalytic domain",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "phosphodiesterase 4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "16c2fe25d90b39e6a907e434c40fd469"
      ],
      "confidence": 0.95,
      "evidence": "phosphodiesterase 4",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Study",
      "name": "Blednov et al. 2014",
      "attributes": {
        "year": 2014,
        "design": "animal study"
      },
      "source_chunk_ids": [
        "16c2fe25d90b39e6a907e434c40fd469"
      ],
      "confidence": 0.9,
      "evidence": "Blednov YA, Benavidez JM, Black M, Harris RA. Inhibition of phosphodiesterase 4 reduces ethanol intake and preference in C57BL/6J mice. Frontiers in neuroscience. 2014; 8:129.",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Evidence",
      "name": "in vivo animal study",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "16c2fe25d90b39e6a907e434c40fd469"
      ],
      "confidence": 0.85,
      "evidence": "animal study in C57BL/6J mice",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "reduced ethanol intake",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "16c2fe25d90b39e6a907e434c40fd469"
      ],
      "confidence": 0.9,
      "evidence": "reduces ethanol intake and preference",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "alcohol drinking",
      "attributes": {
        "condition_type": "behavior"
      },
      "source_chunk_ids": [
        "16c2fe25d90b39e6a907e434c40fd469"
      ],
      "confidence": 0.85,
      "evidence": "ethanol intake and preference",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Study",
      "name": "Franklin et al. 2015",
      "attributes": {
        "year": 2015,
        "design": "animal study"
      },
      "source_chunk_ids": [
        "16c2fe25d90b39e6a907e434c40fd469"
      ],
      "confidence": 0.9,
      "evidence": "Franklin KM, Hauser SR, Lasek AW, McClintick J, Ding ZM, McBride WJ, Bell RL. Reduction of alcohol drinking of alcohol-preferring (P) and high-alcohol drinking (HAD1) rats by targeting phosphodiesterase-4 (PDE4). Psychopharmacology (Berl). 2015; 232:2251\u20132262.",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "reduction of alcohol drinking",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "16c2fe25d90b39e6a907e434c40fd469"
      ],
      "confidence": 0.9,
      "evidence": "Reduction of alcohol drinking",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Study",
      "name": "Fleischhacker et al. 1992",
      "attributes": {
        "year": 1992,
        "design": "double-blind study"
      },
      "source_chunk_ids": [
        "16c2fe25d90b39e6a907e434c40fd469"
      ],
      "confidence": 0.9,
      "evidence": "Fleischhacker WW, Hinterhuber H, Bauer H, Pflug B, Berner P, Simhandl C, Wolf R, Gerlach W, Jaklitsch H, Sastre-y-Hernandez M, et al. A multicenter double-blind study of three different doses of the new cAMP-phosphodiesterase inhibitor rolipram in patients with major depressive disorder. Neuropsychobiology. 1992; 26:59\u201364.",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Evidence",
      "name": "clinical trial",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "16c2fe25d90b39e6a907e434c40fd469"
      ],
      "confidence": 0.85,
      "evidence": "multicenter double-blind study",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {},
      "source_chunk_ids": [
        "16c2fe25d90b39e6a907e434c40fd469"
      ],
      "confidence": 0.95,
      "evidence": "rolipram",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Condition",
      "name": "major depressive disorder",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "16c2fe25d90b39e6a907e434c40fd469"
      ],
      "confidence": 0.9,
      "evidence": "major depressive disorder",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Study",
      "name": "Hamdy et al. 2001",
      "attributes": {
        "year": 2001,
        "design": "animal study"
      },
      "source_chunk_ids": [
        "16c2fe25d90b39e6a907e434c40fd469"
      ],
      "confidence": 0.9,
      "evidence": "Hamdy MM, Mamiya T, Noda Y, Sayed M, Assi AA, Gomaa A, Yamada K, Nabeshima T. A selective phosphodiesterase IV inhibitor, rolipram blocks both withdrawal behavioral manifestations, and c-Fos protein expression in morphine dependent mice. Behavioural brain research. 2001; 118:85\u201393.",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Effect",
      "name": "blocks withdrawal behavioral manifestations",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "16c2fe25d90b39e6a907e434c40fd469"
      ],
      "confidence": 0.85,
      "evidence": "blocks both withdrawal behavioral manifestations",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Condition",
      "name": "morphine withdrawal",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "16c2fe25d90b39e6a907e434c40fd469"
      ],
      "confidence": 0.8,
      "evidence": "morphine dependent mice",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Study",
      "name": "Gonzalez-Cuello et al. 2007",
      "attributes": {
        "year": 2007,
        "design": "animal study"
      },
      "source_chunk_ids": [
        "16c2fe25d90b39e6a907e434c40fd469"
      ],
      "confidence": 0.9,
      "evidence": "Gonzalez-Cuello A, Sanchez L, Hernandez J, Teresa Castells M, Victoria Milanes M, Laorden ML. Phosphodiesterase 4 inhibitors, rolipram and diazepam block the adaptive changes observed during morphine withdrawal in the heart. European journal of pharmacology. 2007; 570:1\u20139.",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Effect",
      "name": "blocks adaptive changes in heart",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "16c2fe25d90b39e6a907e434c40fd469"
      ],
      "confidence": 0.8,
      "evidence": "block the adaptive changes observed during morphine withdrawal in the heart",
      "verified": true
    },
    {
      "id": "E17",
      "type": "Compound",
      "name": "diazepam",
      "attributes": {},
      "source_chunk_ids": [
        "16c2fe25d90b39e6a907e434c40fd469"
      ],
      "confidence": 0.95,
      "evidence": "diazepam",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {},
      "source_chunk_ids": [
        "109a66f50c7a6ac2fa180c17a6ad0933"
      ],
      "confidence": 0.95,
      "evidence": "Rolipram (open circles)",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Compound",
      "name": "Ro 20-1724",
      "attributes": {},
      "source_chunk_ids": [
        "109a66f50c7a6ac2fa180c17a6ad0933"
      ],
      "confidence": 0.95,
      "evidence": "Ro 20-1724 (filled circles)",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "109a66f50c7a6ac2fa180c17a6ad0933"
      ],
      "confidence": 0.9,
      "evidence": "PDE4 inhibitors",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "blocked I-LTD",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "109a66f50c7a6ac2fa180c17a6ad0933"
      ],
      "confidence": 0.85,
      "evidence": "blocked I-LTD",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "I-LTD induction",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "109a66f50c7a6ac2fa180c17a6ad0933"
      ],
      "confidence": 0.8,
      "evidence": "induces I-LTD",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {},
      "source_chunk_ids": [
        "109a66f50c7a6ac2fa180c17a6ad0933"
      ],
      "confidence": 0.9,
      "evidence": "cocaine (A)",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Compound",
      "name": "quinpirole",
      "attributes": {},
      "source_chunk_ids": [
        "109a66f50c7a6ac2fa180c17a6ad0933"
      ],
      "confidence": 0.9,
      "evidence": "quinpirole (B)",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "VTA dopamine neurons",
      "attributes": {
        "target_type": "cell_type"
      },
      "source_chunk_ids": [
        "109a66f50c7a6ac2fa180c17a6ad0933"
      ],
      "confidence": 0.85,
      "evidence": "VTA dopamine neurons",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {},
      "source_chunk_ids": [
        "e03dc3ab5ee086ee9a8fa852c4564f9c"
      ],
      "confidence": 0.95,
      "evidence": "PDE4 inhibitors rolipram",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Compound",
      "name": "Ro 20-1724",
      "attributes": {},
      "source_chunk_ids": [
        "e03dc3ab5ee086ee9a8fa852c4564f9c"
      ],
      "confidence": 0.95,
      "evidence": "PDE4 inhibitors Ro 20-1724",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {},
      "source_chunk_ids": [
        "e03dc3ab5ee086ee9a8fa852c4564f9c"
      ],
      "confidence": 0.9,
      "evidence": "presence of cocaine (3 \u03bcM)",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Compound",
      "name": "quinpirole",
      "attributes": {},
      "source_chunk_ids": [
        "e03dc3ab5ee086ee9a8fa852c4564f9c"
      ],
      "confidence": 0.9,
      "evidence": "D2 receptor agonist quinpirole",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "PDE4",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "e03dc3ab5ee086ee9a8fa852c4564f9c"
      ],
      "confidence": 0.85,
      "evidence": "Selective PDE4 inhibitors",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "D2 receptor",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "e03dc3ab5ee086ee9a8fa852c4564f9c"
      ],
      "confidence": 0.85,
      "evidence": "D2 receptor agonist quinpirole",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "I-LTD in VTA dopamine neurons",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "e03dc3ab5ee086ee9a8fa852c4564f9c"
      ],
      "confidence": 0.9,
      "evidence": "induced I-LTD in VTA dopamine neurons",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "blocked I-LTD",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "e03dc3ab5ee086ee9a8fa852c4564f9c"
      ],
      "confidence": 0.9,
      "evidence": "blocked I-LTD in VTA dopamine neurons",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Study",
      "name": "Neuropsychopharmacology study",
      "attributes": {
        "design": "in vitro electrophysiology",
        "year": "not specified",
        "doi": "not specified"
      },
      "source_chunk_ids": [
        "e03dc3ab5ee086ee9a8fa852c4564f9c"
      ],
      "confidence": 0.8,
      "evidence": "used with the permission of Neuropsychopharmacology",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "e03dc3ab5ee086ee9a8fa852c4564f9c"
      ],
      "confidence": 0.85,
      "evidence": "whole-cell recordings in VTA dopamine neurons",
      "verified": true
    }
  ],
  "relationships": [
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E4",
      "attributes": {
        "context": "neuroadaptation"
      },
      "confidence": 0.7,
      "evidence": "thought to underlie aspects of drug tolerance",
      "source_chunk_ids": [
        "2b1b0fb78e7bf9d3917894168b0d5e5b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E5",
      "attributes": {
        "context": "neuroadaptation"
      },
      "confidence": 0.7,
      "evidence": "thought to underlie aspects of drug tolerance and dependence",
      "source_chunk_ids": [
        "2b1b0fb78e7bf9d3917894168b0d5e5b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E2",
      "target_entity_id": "E1",
      "attributes": {
        "action": "hydrolyzes"
      },
      "confidence": 0.75,
      "evidence": "hydrolyzes intracellular cAMP",
      "source_chunk_ids": [
        "2b1b0fb78e7bf9d3917894168b0d5e5b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E6",
      "attributes": {
        "context": "enzymatic",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "PDE4 hydrolyzes cAMP, related to up-regulation",
      "source_chunk_ids": [
        "2b1b0fb78e7bf9d3917894168b0d5e5b"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.8,
      "evidence": "PDE4 inhibitors reduce drug intake",
      "source_chunk_ids": [
        "46817a691bbdc4285014bccc8ae83f6a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.8,
      "evidence": "PDE4 inhibitors reduce drug seeking",
      "source_chunk_ids": [
        "46817a691bbdc4285014bccc8ae83f6a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "TREATS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "context": "preclinical"
      },
      "confidence": 0.75,
      "evidence": "reduce drug intake for psychostimulants",
      "source_chunk_ids": [
        "46817a691bbdc4285014bccc8ae83f6a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "TREATS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "context": "preclinical"
      },
      "confidence": 0.75,
      "evidence": "reduce drug intake for alcohol",
      "source_chunk_ids": [
        "46817a691bbdc4285014bccc8ae83f6a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "TREATS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "context": "preclinical"
      },
      "confidence": 0.75,
      "evidence": "reduce drug intake for opioids",
      "source_chunk_ids": [
        "46817a691bbdc4285014bccc8ae83f6a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E7",
      "target_entity_id": "E1",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "studies have shown that PDE4 inhibitors reduce",
      "source_chunk_ids": [
        "46817a691bbdc4285014bccc8ae83f6a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "TREATS",
      "source_entity_id": "E3",
      "target_entity_id": "E2",
      "attributes": {
        "context": "preclinical"
      },
      "confidence": 0.7,
      "evidence": "PDE4 inhibitors for substance use disorder",
      "source_chunk_ids": [
        "449c3c7682d3812e3c88a8129f5d60a7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "TREATS",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {
        "context": "clinical repurposing",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "repurpose these PDE4 inhibitors for drug addiction",
      "source_chunk_ids": [
        "449c3c7682d3812e3c88a8129f5d60a7"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R3",
      "type": "CAUSES",
      "source_entity_id": "E3",
      "target_entity_id": "E6",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.7,
      "evidence": "side effects that limit the clinical potential",
      "source_chunk_ids": [
        "449c3c7682d3812e3c88a8129f5d60a7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "SUGGESTS",
      "source_entity_id": "E5",
      "target_entity_id": "E2",
      "attributes": {
        "mapping_type": "direct"
      },
      "confidence": 0.75,
      "evidence": "Preclinical studies suggest PDE4 target for substance use disorder",
      "source_chunk_ids": [
        "449c3c7682d3812e3c88a8129f5d60a7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "SUGGESTS",
      "source_entity_id": "E7",
      "target_entity_id": "E1",
      "attributes": {
        "mapping_type": "indirect"
      },
      "confidence": 0.7,
      "evidence": "PDE4 inhibitors reduce drug intake",
      "source_chunk_ids": [
        "891928bec7637c2d4902145f4426753c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "SUGGESTS",
      "source_entity_id": "E7",
      "target_entity_id": "E2",
      "attributes": {
        "mapping_type": "indirect"
      },
      "confidence": 0.7,
      "evidence": "PDE4 inhibitors reduce drug intake for alcohol",
      "source_chunk_ids": [
        "891928bec7637c2d4902145f4426753c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "SUGGESTS",
      "source_entity_id": "E7",
      "target_entity_id": "E6",
      "attributes": {
        "mapping_type": "indirect"
      },
      "confidence": 0.7,
      "evidence": "PDE4 inhibitors reduce drug intake for psychostimulants",
      "source_chunk_ids": [
        "891928bec7637c2d4902145f4426753c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {
        "action": "inhibition"
      },
      "confidence": 0.75,
      "evidence": "PDE4 inhibitors reduce drug intake",
      "source_chunk_ids": [
        "891928bec7637c2d4902145f4426753c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E5",
      "attributes": {
        "action": "inhibition"
      },
      "confidence": 0.75,
      "evidence": "PDE4 inhibitors reduce drug seeking",
      "source_chunk_ids": [
        "891928bec7637c2d4902145f4426753c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "TREATS",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "context": "preclinical"
      },
      "confidence": 0.8,
      "evidence": "PDE4 could be a therapeutic target for several classes of substance use disorder",
      "source_chunk_ids": [
        "aeed08f92815866e113bc2e79743ce0f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "PDE4 inhibitors reduce drug intake and/or drug seeking",
      "source_chunk_ids": [
        "aeed08f92815866e113bc2e79743ce0f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "PDE4 inhibitors can break down such compartmentalization and causes widespread increase in intracellular cAMP levels",
      "source_chunk_ids": [
        "aeed08f92815866e113bc2e79743ce0f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "PDE4 inhibitors may disrupt or occlude cAMP-related neuroadaptations",
      "source_chunk_ids": [
        "aeed08f92815866e113bc2e79743ce0f"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R5",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E7",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "review of current knowledge",
      "source_chunk_ids": [
        "aeed08f92815866e113bc2e79743ce0f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "STUDIES",
      "source_entity_id": "E7",
      "target_entity_id": "E1",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.75,
      "evidence": "review about PDE4 isoforms and effects",
      "source_chunk_ids": [
        "aeed08f92815866e113bc2e79743ce0f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "observed"
      },
      "confidence": 0.7,
      "evidence": "PDE4 inhibitors reduce drug intake and/or drug seeking",
      "source_chunk_ids": [
        "aeed08f92815866e113bc2e79743ce0f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E2",
      "target_entity_id": "E3",
      "attributes": {
        "action": "targets",
        "context": "therapeutic"
      },
      "confidence": 0.8,
      "evidence": "PDE4 has emerged as a potential therapeutic target for the treatment of substance abuse",
      "source_chunk_ids": [
        "70c87099b86a655798c3ca681fc97782"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "ACTS_ON",
      "source_entity_id": "E2",
      "target_entity_id": "E4",
      "attributes": {
        "action": "targets",
        "context": "therapeutic"
      },
      "confidence": 0.8,
      "evidence": "PDE4 has emerged as a potential therapeutic target for the treatment of substance use disorders",
      "source_chunk_ids": [
        "70c87099b86a655798c3ca681fc97782"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "REPORTS",
      "source_entity_id": "E6",
      "target_entity_id": "E1",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "MacKenzie and Houslay, 2000",
      "source_chunk_ids": [
        "4680e584ca7433423b40cfd417fdcd3e"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E1",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "Wang et al., 2015",
      "source_chunk_ids": [
        "4680e584ca7433423b40cfd417fdcd3e"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E1",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "Johansson et al., 2012",
      "source_chunk_ids": [
        "4680e584ca7433423b40cfd417fdcd3e"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E1",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "Perez-Torres et al., 2000",
      "source_chunk_ids": [
        "4680e584ca7433423b40cfd417fdcd3e"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E10",
      "target_entity_id": "E1",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "Lakics et al., 2010",
      "source_chunk_ids": [
        "4680e584ca7433423b40cfd417fdcd3e"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E6",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "PDE4B mRNA is high",
      "source_chunk_ids": [
        "ecad62b522b0b291519e8b5fe3d6fadc"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E7",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "PDE4B-immunopositive neurons",
      "source_chunk_ids": [
        "ecad62b522b0b291519e8b5fe3d6fadc"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E8",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "direct pathway is behaviorally stimulating",
      "source_chunk_ids": [
        "ecad62b522b0b291519e8b5fe3d6fadc"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E9",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "expression of PDE4B was higher",
      "source_chunk_ids": [
        "ecad62b522b0b291519e8b5fe3d6fadc"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E10",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "PDE4A mRNA was elevated",
      "source_chunk_ids": [
        "ecad62b522b0b291519e8b5fe3d6fadc"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E6",
      "target_entity_id": "E1",
      "attributes": {
        "outcome": "present"
      },
      "confidence": 0.8,
      "evidence": "PDE4B mRNA is high",
      "source_chunk_ids": [
        "ecad62b522b0b291519e8b5fe3d6fadc"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E6",
      "target_entity_id": "E2",
      "attributes": {
        "outcome": "present"
      },
      "confidence": 0.8,
      "evidence": "PDE4A mRNA levels are present",
      "source_chunk_ids": [
        "ecad62b522b0b291519e8b5fe3d6fadc"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "REPORTS",
      "source_entity_id": "E6",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "present"
      },
      "confidence": 0.8,
      "evidence": "PDE4D mRNA levels are present",
      "source_chunk_ids": [
        "ecad62b522b0b291519e8b5fe3d6fadc"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E1",
      "attributes": {
        "outcome": "present"
      },
      "confidence": 0.8,
      "evidence": "PDE4B-immunopositive neurons",
      "source_chunk_ids": [
        "ecad62b522b0b291519e8b5fe3d6fadc"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "present"
      },
      "confidence": 0.75,
      "evidence": "dopamine D1 receptor-expressing",
      "source_chunk_ids": [
        "ecad62b522b0b291519e8b5fe3d6fadc"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "present"
      },
      "confidence": 0.75,
      "evidence": "dopamine D2 receptor-expressing",
      "source_chunk_ids": [
        "ecad62b522b0b291519e8b5fe3d6fadc"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E12",
      "attributes": {
        "outcome": "present"
      },
      "confidence": 0.7,
      "evidence": "direct pathway is behaviorally stimulating",
      "source_chunk_ids": [
        "ecad62b522b0b291519e8b5fe3d6fadc"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E13",
      "attributes": {
        "outcome": "present"
      },
      "confidence": 0.7,
      "evidence": "indirect pathway is behaviorally suppressant",
      "source_chunk_ids": [
        "ecad62b522b0b291519e8b5fe3d6fadc"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E1",
      "attributes": {
        "outcome": "present"
      },
      "confidence": 0.8,
      "evidence": "expression of PDE4B was higher",
      "source_chunk_ids": [
        "ecad62b522b0b291519e8b5fe3d6fadc"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R15",
      "type": "REPORTS",
      "source_entity_id": "E10",
      "target_entity_id": "E2",
      "attributes": {
        "outcome": "elevated"
      },
      "confidence": 0.8,
      "evidence": "PDE4A mRNA was elevated",
      "source_chunk_ids": [
        "ecad62b522b0b291519e8b5fe3d6fadc"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R16",
      "type": "REPORTS",
      "source_entity_id": "E10",
      "target_entity_id": "E1",
      "attributes": {
        "outcome": "reduced"
      },
      "confidence": 0.8,
      "evidence": "PDE4B2 mRNA was reduced",
      "source_chunk_ids": [
        "ecad62b522b0b291519e8b5fe3d6fadc"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "REPORTS",
      "source_entity_id": "E4",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "PDE4A and 4B mRNA are low",
      "source_chunk_ids": [
        "4f33a38c7a2ce01b0bf10011585e4714"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E4",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "PDE4D was not detected",
      "source_chunk_ids": [
        "4f33a38c7a2ce01b0bf10011585e4714"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E5",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "mRNA analyzed by quantitative real-time PCR",
      "source_chunk_ids": [
        "4f33a38c7a2ce01b0bf10011585e4714"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E6",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Protein expression in rodents",
      "source_chunk_ids": [
        "4f33a38c7a2ce01b0bf10011585e4714"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "PDE4B2 mRNA was elevated",
      "source_chunk_ids": [
        "4f33a38c7a2ce01b0bf10011585e4714"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "REPORTS",
      "source_entity_id": "E4",
      "target_entity_id": "E1",
      "attributes": {
        "outcome": "expressed"
      },
      "confidence": 0.8,
      "evidence": "PDE4A and 4D proteins are expressed",
      "source_chunk_ids": [
        "f02199c8c1b5b80f267b587d4167a1d1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E4",
      "target_entity_id": "E2",
      "attributes": {
        "outcome": "expressed"
      },
      "confidence": 0.8,
      "evidence": "PDE4B is reported to be present",
      "source_chunk_ids": [
        "f02199c8c1b5b80f267b587d4167a1d1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E4",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "expressed"
      },
      "confidence": 0.8,
      "evidence": "PDE4A and 4D proteins are expressed",
      "source_chunk_ids": [
        "f02199c8c1b5b80f267b587d4167a1d1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E2",
      "attributes": {
        "outcome": "expressed"
      },
      "confidence": 0.8,
      "evidence": "PDE4B is reported to be present",
      "source_chunk_ids": [
        "f02199c8c1b5b80f267b587d4167a1d1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E6",
      "target_entity_id": "E1",
      "attributes": {
        "outcome": "abundant"
      },
      "confidence": 0.8,
      "evidence": "PDE4B is the most abundant isoform",
      "source_chunk_ids": [
        "f02199c8c1b5b80f267b587d4167a1d1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E6",
      "target_entity_id": "E2",
      "attributes": {
        "outcome": "abundant"
      },
      "confidence": 0.8,
      "evidence": "PDE4B is the most abundant isoform",
      "source_chunk_ids": [
        "f02199c8c1b5b80f267b587d4167a1d1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E6",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "abundant"
      },
      "confidence": 0.8,
      "evidence": "followed by 4A, then 4D",
      "source_chunk_ids": [
        "f02199c8c1b5b80f267b587d4167a1d1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E5",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Studies investigating PDE4",
      "source_chunk_ids": [
        "69bcdc3130c9db875524e27476075c78"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E6",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Studies investigating PDE4",
      "source_chunk_ids": [
        "69bcdc3130c9db875524e27476075c78"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E7",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Studies investigating PDE4",
      "source_chunk_ids": [
        "69bcdc3130c9db875524e27476075c78"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "STUDIES",
      "source_entity_id": "E5",
      "target_entity_id": "E1",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.8,
      "evidence": "Studies investigating PDE4",
      "source_chunk_ids": [
        "69bcdc3130c9db875524e27476075c78"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "STUDIES",
      "source_entity_id": "E6",
      "target_entity_id": "E1",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.8,
      "evidence": "Studies investigating PDE4",
      "source_chunk_ids": [
        "69bcdc3130c9db875524e27476075c78"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "STUDIES",
      "source_entity_id": "E7",
      "target_entity_id": "E3",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.8,
      "evidence": "PDE4B1 mRNA was decreased",
      "source_chunk_ids": [
        "69bcdc3130c9db875524e27476075c78"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E5",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "rodents do not have an emetic reflex",
      "source_chunk_ids": [
        "967608e5a5c8b66e1d97fd5b46d09333"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E6",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "PDE4D mRNA is the highest",
      "source_chunk_ids": [
        "967608e5a5c8b66e1d97fd5b46d09333"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E7",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "similar pattern in rat brain",
      "source_chunk_ids": [
        "967608e5a5c8b66e1d97fd5b46d09333"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E8",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "PDE4D protein detected in mouse",
      "source_chunk_ids": [
        "967608e5a5c8b66e1d97fd5b46d09333"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E1",
      "attributes": {
        "outcome": "no_effect"
      },
      "confidence": 0.75,
      "evidence": "rodents do not have an emetic reflex",
      "source_chunk_ids": [
        "967608e5a5c8b66e1d97fd5b46d09333"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E6",
      "target_entity_id": "E2",
      "attributes": {
        "outcome": "present"
      },
      "confidence": 0.8,
      "evidence": "PDE4D mRNA is the highest",
      "source_chunk_ids": [
        "967608e5a5c8b66e1d97fd5b46d09333"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E6",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "present"
      },
      "confidence": 0.8,
      "evidence": "PDE4B is present in modest amounts",
      "source_chunk_ids": [
        "967608e5a5c8b66e1d97fd5b46d09333"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "REPORTS",
      "source_entity_id": "E6",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "barely detectable"
      },
      "confidence": 0.8,
      "evidence": "PDE4A barely detectable",
      "source_chunk_ids": [
        "967608e5a5c8b66e1d97fd5b46d09333"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E1",
      "attributes": {
        "outcome": "similar pattern"
      },
      "confidence": 0.75,
      "evidence": "similar pattern in rat brain",
      "source_chunk_ids": [
        "967608e5a5c8b66e1d97fd5b46d09333"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E2",
      "attributes": {
        "outcome": "detected"
      },
      "confidence": 0.8,
      "evidence": "PDE4D protein detected in mouse",
      "source_chunk_ids": [
        "967608e5a5c8b66e1d97fd5b46d09333"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "not detected"
      },
      "confidence": 0.8,
      "evidence": "PDE4B protein was not",
      "source_chunk_ids": [
        "967608e5a5c8b66e1d97fd5b46d09333"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "study measuring PDE4 isoforms",
      "source_chunk_ids": [
        "7b9af0fbb00b3348fc67553bb9d80568"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.8,
      "evidence": "PDE4D mRNA was the highest",
      "source_chunk_ids": [
        "7b9af0fbb00b3348fc67553bb9d80568"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.75,
      "evidence": "4B was lower",
      "source_chunk_ids": [
        "7b9af0fbb00b3348fc67553bb9d80568"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.7,
      "evidence": "4A was not detected",
      "source_chunk_ids": [
        "7b9af0fbb00b3348fc67553bb9d80568"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "measured"
      },
      "confidence": 0.8,
      "evidence": "measuring PDE4 isoforms in the dorsal vagal motor nucleus",
      "source_chunk_ids": [
        "7b9af0fbb00b3348fc67553bb9d80568"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "confidence": 0.7,
      "evidence": "may reflect increased craving",
      "source_chunk_ids": [
        "bee7a29b02c1447c8b021b6121a1e76a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E8",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "confidence": 0.8,
      "evidence": "reinstatement of drug seeking is a measure of drug seeking",
      "source_chunk_ids": [
        "bee7a29b02c1447c8b021b6121a1e76a"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "cocaine infusion... discriminative stimulus effects",
      "source_chunk_ids": [
        "1a0f027a9bfa2d7c8372f363fd5cebb4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Psychoactive drugs produce subjective feelings",
      "source_chunk_ids": [
        "1a0f027a9bfa2d7c8372f363fd5cebb4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E5",
      "target_entity_id": "E6",
      "attributes": {
        "action": "antagonist"
      },
      "confidence": 0.85,
      "evidence": "antagonist of the benzodiazepine binding site",
      "source_chunk_ids": [
        "1a0f027a9bfa2d7c8372f363fd5cebb4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "rats trained to discriminate diazepam",
      "source_chunk_ids": [
        "1a0f027a9bfa2d7c8372f363fd5cebb4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E8",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "treatment with amphetamine... cocaine-appropriate responding",
      "source_chunk_ids": [
        "1a0f027a9bfa2d7c8372f363fd5cebb4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "series of studies in rodents",
      "source_chunk_ids": [
        "eb5a7bdfd928436fff356fb03c4dcdaa"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "examined the effects of rolipram",
      "source_chunk_ids": [
        "eb5a7bdfd928436fff356fb03c4dcdaa"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.9,
      "evidence": "selective PDE4 inhibitor rolipram",
      "source_chunk_ids": [
        "eb5a7bdfd928436fff356fb03c4dcdaa"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "reduces"
      },
      "confidence": 0.85,
      "evidence": "PDE4 inhibition reduces cocaine reward",
      "source_chunk_ids": [
        "eb5a7bdfd928436fff356fb03c4dcdaa"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "reduces"
      },
      "confidence": 0.8,
      "evidence": "reduces incentive saliency",
      "source_chunk_ids": [
        "eb5a7bdfd928436fff356fb03c4dcdaa"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "reduces"
      },
      "confidence": 0.8,
      "evidence": "reduces seeking in rodents",
      "source_chunk_ids": [
        "eb5a7bdfd928436fff356fb03c4dcdaa"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E8",
      "attributes": {
        "outcome": "reduces"
      },
      "confidence": 0.85,
      "evidence": "greatly reduced cocaine-induced hyperlocomotor activity",
      "source_chunk_ids": [
        "eb5a7bdfd928436fff356fb03c4dcdaa"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E9",
      "attributes": {
        "outcome": "reduces"
      },
      "confidence": 0.85,
      "evidence": "reduce expression of behavioral sensitization",
      "source_chunk_ids": [
        "eb5a7bdfd928436fff356fb03c4dcdaa"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E10",
      "attributes": {
        "outcome": "observed"
      },
      "confidence": 0.8,
      "evidence": "greatly reduced cocaine-induced hyperlocomotor activity",
      "source_chunk_ids": [
        "eb5a7bdfd928436fff356fb03c4dcdaa"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E11",
      "attributes": {
        "outcome": "observed"
      },
      "confidence": 0.75,
      "evidence": "reduced the locomotor response to a challenge dose",
      "source_chunk_ids": [
        "eb5a7bdfd928436fff356fb03c4dcdaa"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E12",
      "attributes": {
        "outcome": "observed"
      },
      "confidence": 0.7,
      "evidence": "reduce expression of behavioral sensitization",
      "source_chunk_ids": [
        "eb5a7bdfd928436fff356fb03c4dcdaa"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "TREATS",
      "source_entity_id": "E3",
      "target_entity_id": "E5",
      "attributes": {
        "context": "preclinical"
      },
      "confidence": 0.8,
      "evidence": "PDE4 inhibition reduces cocaine reward",
      "source_chunk_ids": [
        "eb5a7bdfd928436fff356fb03c4dcdaa"
      ],
      "supporting_study_ids": [
        "E1"
      ],
      "verified": true
    },
    {
      "id": "R13",
      "type": "TREATS",
      "source_entity_id": "E3",
      "target_entity_id": "E6",
      "attributes": {
        "context": "preclinical"
      },
      "confidence": 0.75,
      "evidence": "reduces incentive saliency",
      "source_chunk_ids": [
        "eb5a7bdfd928436fff356fb03c4dcdaa"
      ],
      "supporting_study_ids": [
        "E1"
      ],
      "verified": true
    },
    {
      "id": "R14",
      "type": "TREATS",
      "source_entity_id": "E3",
      "target_entity_id": "E7",
      "attributes": {
        "context": "preclinical"
      },
      "confidence": 0.75,
      "evidence": "reduces seeking in rodents",
      "source_chunk_ids": [
        "eb5a7bdfd928436fff356fb03c4dcdaa"
      ],
      "supporting_study_ids": [
        "E1"
      ],
      "verified": true
    },
    {
      "id": "R15",
      "type": "TREATS",
      "source_entity_id": "E3",
      "target_entity_id": "E8",
      "attributes": {
        "context": "preclinical"
      },
      "confidence": 0.8,
      "evidence": "greatly reduced cocaine-induced hyperlocomotor activity",
      "source_chunk_ids": [
        "eb5a7bdfd928436fff356fb03c4dcdaa"
      ],
      "supporting_study_ids": [
        "E1"
      ],
      "verified": true
    },
    {
      "id": "R16",
      "type": "TREATS",
      "source_entity_id": "E3",
      "target_entity_id": "E9",
      "attributes": {
        "context": "preclinical"
      },
      "confidence": 0.8,
      "evidence": "reduce expression of behavioral sensitization",
      "source_chunk_ids": [
        "eb5a7bdfd928436fff356fb03c4dcdaa"
      ],
      "supporting_study_ids": [
        "E1"
      ],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "PDE4 inhibition",
      "source_chunk_ids": [
        "fb39eb6890494fdcaa8c73d29e6a18a3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "cocaine-induced increase in locomotor activity",
      "source_chunk_ids": [
        "fb39eb6890494fdcaa8c73d29e6a18a3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "locomotor sensitization",
      "source_chunk_ids": [
        "fb39eb6890494fdcaa8c73d29e6a18a3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E6",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "no_effect"
      },
      "confidence": 0.75,
      "evidence": "did not affect the cocaine-induced increase in locomotor activity",
      "source_chunk_ids": [
        "fb39eb6890494fdcaa8c73d29e6a18a3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E6",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "no_effect"
      },
      "confidence": 0.75,
      "evidence": "did not affect locomotor sensitization",
      "source_chunk_ids": [
        "fb39eb6890494fdcaa8c73d29e6a18a3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E6",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Janes et al., 2009",
      "source_chunk_ids": [
        "fb39eb6890494fdcaa8c73d29e6a18a3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "STUDIES",
      "source_entity_id": "E6",
      "target_entity_id": "E1",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "Administration of rolipram",
      "source_chunk_ids": [
        "fb39eb6890494fdcaa8c73d29e6a18a3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "STUDIES",
      "source_entity_id": "E6",
      "target_entity_id": "E2",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "cocaine injection",
      "source_chunk_ids": [
        "fb39eb6890494fdcaa8c73d29e6a18a3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "ACTS_ON",
      "source_entity_id": "E8",
      "target_entity_id": "E9",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "PDE inhibitor",
      "source_chunk_ids": [
        "fb39eb6890494fdcaa8c73d29e6a18a3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "acute hyperlocomotor response to cocaine",
      "source_chunk_ids": [
        "fb39eb6890494fdcaa8c73d29e6a18a3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "behavioral sensitization",
      "source_chunk_ids": [
        "fb39eb6890494fdcaa8c73d29e6a18a3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "REPORTS",
      "source_entity_id": "E12",
      "target_entity_id": "E10",
      "attributes": {
        "outcome": "no_effect"
      },
      "confidence": 0.75,
      "evidence": "does not affect the acute hyperlocomotor response",
      "source_chunk_ids": [
        "fb39eb6890494fdcaa8c73d29e6a18a3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "REPORTS",
      "source_entity_id": "E12",
      "target_entity_id": "E11",
      "attributes": {
        "outcome": "reduces"
      },
      "confidence": 0.8,
      "evidence": "reduces the development of behavioral sensitization",
      "source_chunk_ids": [
        "fb39eb6890494fdcaa8c73d29e6a18a3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E12",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Schroeder et al., 2012",
      "source_chunk_ids": [
        "fb39eb6890494fdcaa8c73d29e6a18a3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R15",
      "type": "STUDIES",
      "source_entity_id": "E12",
      "target_entity_id": "E8",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "intracerebroventricular injection of isobutylmethylxanthine",
      "source_chunk_ids": [
        "fb39eb6890494fdcaa8c73d29e6a18a3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R16",
      "type": "STUDIES",
      "source_entity_id": "E12",
      "target_entity_id": "E2",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "response to cocaine",
      "source_chunk_ids": [
        "fb39eb6890494fdcaa8c73d29e6a18a3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "PDE4 inhibitors are known to enhance cognitive functions",
      "source_chunk_ids": [
        "2ef34a1ed1be70250b108ff951406441"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "cognitive functions such as learning",
      "source_chunk_ids": [
        "2ef34a1ed1be70250b108ff951406441"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "cognitive functions such as memory",
      "source_chunk_ids": [
        "2ef34a1ed1be70250b108ff951406441"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "TREATS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "context": "proposed"
      },
      "confidence": 0.7,
      "evidence": "proposed as potential pharmacotherapy of cognitive decline",
      "source_chunk_ids": [
        "2ef34a1ed1be70250b108ff951406441"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E2",
      "target_entity_id": "E1",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.9,
      "evidence": "PDE4 inhibitor rolipram",
      "source_chunk_ids": [
        "438eaeeff2ddb78e0179c22025e30a45"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Thompson et al., 2004 study",
      "source_chunk_ids": [
        "438eaeeff2ddb78e0179c22025e30a45"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "STUDIES",
      "source_entity_id": "E3",
      "target_entity_id": "E2",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "Systemic injections of rolipram",
      "source_chunk_ids": [
        "438eaeeff2ddb78e0179c22025e30a45"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E3",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "attenuates"
      },
      "confidence": 0.8,
      "evidence": "rolipram attenuates the acquisition of CPP",
      "source_chunk_ids": [
        "438eaeeff2ddb78e0179c22025e30a45"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E3",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "no_effect"
      },
      "confidence": 0.75,
      "evidence": "does not alter expression of CPP",
      "source_chunk_ids": [
        "438eaeeff2ddb78e0179c22025e30a45"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E3",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "no_effect"
      },
      "confidence": 0.7,
      "evidence": "no place aversion or memory impairment",
      "source_chunk_ids": [
        "438eaeeff2ddb78e0179c22025e30a45"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "rolipram attenuates acquisition",
      "source_chunk_ids": [
        "438eaeeff2ddb78e0179c22025e30a45"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E6",
      "attributes": {
        "assertion": "refutes"
      },
      "confidence": 0.7,
      "evidence": "does not alter expression",
      "source_chunk_ids": [
        "438eaeeff2ddb78e0179c22025e30a45"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E7",
      "attributes": {
        "assertion": "refutes",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "no place aversion or impairment",
      "source_chunk_ids": [
        "438eaeeff2ddb78e0179c22025e30a45"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R10",
      "type": "TREATS",
      "source_entity_id": "E2",
      "target_entity_id": "E8",
      "attributes": {
        "context": "experimental",
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "dampen formation of drug-cue memories",
      "source_chunk_ids": [
        "438eaeeff2ddb78e0179c22025e30a45"
      ],
      "supporting_study_ids": [
        "E3"
      ],
      "verified": false
    },
    {
      "id": "R1",
      "type": "STUDIES",
      "source_entity_id": "E3",
      "target_entity_id": "E12",
      "attributes": {
        "role": "condition"
      },
      "confidence": 0.75,
      "evidence": "mice were conditioned by escalating doses of cocaine",
      "source_chunk_ids": [
        "d4c4e0812d48aeb817361c3603c67985"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E4",
      "target_entity_id": "E5",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.8,
      "evidence": "BAY-73-6691 facilitated extinction",
      "source_chunk_ids": [
        "d4c4e0812d48aeb817361c3603c67985"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "STUDIES",
      "source_entity_id": "E4",
      "target_entity_id": "E6",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.8,
      "evidence": "rolipram did not have a significant effect",
      "source_chunk_ids": [
        "d4c4e0812d48aeb817361c3603c67985"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E4",
      "target_entity_id": "E9",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "facilitated extinction",
      "source_chunk_ids": [
        "d4c4e0812d48aeb817361c3603c67985"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E4",
      "target_entity_id": "E10",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "reduced cocaine primed reinstatement",
      "source_chunk_ids": [
        "d4c4e0812d48aeb817361c3603c67985"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E4",
      "target_entity_id": "E11",
      "attributes": {
        "outcome": "no_effect"
      },
      "confidence": 0.75,
      "evidence": "did not have a significant effect",
      "source_chunk_ids": [
        "d4c4e0812d48aeb817361c3603c67985"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "ACTS_ON",
      "source_entity_id": "E5",
      "target_entity_id": "E7",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "PDE9 inhibitor BAY-73-6691",
      "source_chunk_ids": [
        "d4c4e0812d48aeb817361c3603c67985"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "ACTS_ON",
      "source_entity_id": "E6",
      "target_entity_id": "E8",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "PDE4 inhibitor rolipram",
      "source_chunk_ids": [
        "d4c4e0812d48aeb817361c3603c67985"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "BAY-73-6691 facilitated extinction",
      "source_chunk_ids": [
        "d4c4e0812d48aeb817361c3603c67985"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "reduced cocaine primed reinstatement",
      "source_chunk_ids": [
        "d4c4e0812d48aeb817361c3603c67985"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "rolipram did not have a significant effect",
      "source_chunk_ids": [
        "d4c4e0812d48aeb817361c3603c67985"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E4",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "mice were conditioned",
      "source_chunk_ids": [
        "d4c4e0812d48aeb817361c3603c67985"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Knapp et al., 1999",
      "source_chunk_ids": [
        "36b1c3f2221deeabc9cdc5585517b080"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "systemic administration of either rolipram",
      "source_chunk_ids": [
        "36b1c3f2221deeabc9cdc5585517b080"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "or Ro 20-1724",
      "source_chunk_ids": [
        "36b1c3f2221deeabc9cdc5585517b080"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "reduces"
      },
      "confidence": 0.8,
      "evidence": "reduction in cocaine intake",
      "source_chunk_ids": [
        "36b1c3f2221deeabc9cdc5585517b080"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "suggests"
      },
      "confidence": 0.75,
      "evidence": "general effect on inhibiting motivated behavior",
      "source_chunk_ids": [
        "36b1c3f2221deeabc9cdc5585517b080"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "suggests"
      },
      "confidence": 0.7,
      "evidence": "PDE4 inhibitors can have sedative effects",
      "source_chunk_ids": [
        "36b1c3f2221deeabc9cdc5585517b080"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E8",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.75,
      "evidence": "PDE4 inhibitors",
      "source_chunk_ids": [
        "36b1c3f2221deeabc9cdc5585517b080"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "ACTS_ON",
      "source_entity_id": "E4",
      "target_entity_id": "E8",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.75,
      "evidence": "PDE4 inhibitors",
      "source_chunk_ids": [
        "36b1c3f2221deeabc9cdc5585517b080"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "general effect on inhibiting motivated behavior",
      "source_chunk_ids": [
        "36b1c3f2221deeabc9cdc5585517b080"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "general effect on inhibiting motivated behavior",
      "source_chunk_ids": [
        "36b1c3f2221deeabc9cdc5585517b080"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E7",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "PDE4 inhibitors can have sedative effects",
      "source_chunk_ids": [
        "36b1c3f2221deeabc9cdc5585517b080"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R12",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E7",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "PDE4 inhibitors can have sedative effects",
      "source_chunk_ids": [
        "36b1c3f2221deeabc9cdc5585517b080"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.9,
      "evidence": "ibudilast inhibits both PDE",
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "ibudilast inhibits ... glial proinflammatory activity",
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "ibudilast ... reduce the methamphetamine-induced increase in locomotor activity",
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "AV1013 reduce the methamphetamine-induced increase in locomotor activity",
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "ibudilast ... reduces methamphetamine self-administration",
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "AV1013 ... reduces methamphetamine self-administration",
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "ibudilast ... reduces ... reinstatement of methamphetamine-seeking",
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "AV1013 ... reduces ... reinstatement of methamphetamine-seeking",
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E8",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "in the rat",
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E9",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "in the rat",
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E10",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "in the rat",
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "STUDIES",
      "source_entity_id": "E8",
      "target_entity_id": "E1",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "Snider et al., 2012 ... ibudilast",
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "STUDIES",
      "source_entity_id": "E8",
      "target_entity_id": "E2",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "Snider et al., 2012 ... AV1013",
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "STUDIES",
      "source_entity_id": "E9",
      "target_entity_id": "E1",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "Snider et al., 2013 ... ibudilast",
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R15",
      "type": "STUDIES",
      "source_entity_id": "E9",
      "target_entity_id": "E2",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "Snider et al., 2013 ... AV1013",
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R16",
      "type": "STUDIES",
      "source_entity_id": "E10",
      "target_entity_id": "E1",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "Beardsley et al., 2010 ... ibudilast",
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R17",
      "type": "STUDIES",
      "source_entity_id": "E10",
      "target_entity_id": "E2",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "Beardsley et al., 2010 ... AV1013",
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R18",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "reduce the methamphetamine-induced increase in locomotor activity",
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R19",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "reduces methamphetamine self-administration",
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R20",
      "type": "REPORTS",
      "source_entity_id": "E10",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "reduces ... reinstatement of methamphetamine-seeking",
      "source_chunk_ids": [
        "f839d290fbab0107b416294971036ff4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "AV1013 shares the anti-inflammatory activity",
      "source_chunk_ids": [
        "d715fd883cc9d85eb2d357cb456f6fa8"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "anti-inflammatory activity of ibudilast",
      "source_chunk_ids": [
        "d715fd883cc9d85eb2d357cb456f6fa8"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "action": "inhibits",
        "outcome": "no_effect"
      },
      "confidence": 0.8,
      "evidence": "only negligibly inhibits PDE",
      "source_chunk_ids": [
        "d715fd883cc9d85eb2d357cb456f6fa8"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E5",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "Snider et al., 2012",
      "source_chunk_ids": [
        "d715fd883cc9d85eb2d357cb456f6fa8"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "STUDIES",
      "source_entity_id": "E5",
      "target_entity_id": "E1",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.8,
      "evidence": "AV1013 shares the anti-inflammatory activity",
      "source_chunk_ids": [
        "d715fd883cc9d85eb2d357cb456f6fa8"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "STUDIES",
      "source_entity_id": "E5",
      "target_entity_id": "E2",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.8,
      "evidence": "anti-inflammatory activity of ibudilast",
      "source_chunk_ids": [
        "d715fd883cc9d85eb2d357cb456f6fa8"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "anti-inflammatory activity",
      "source_chunk_ids": [
        "d715fd883cc9d85eb2d357cb456f6fa8"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "no_effect"
      },
      "confidence": 0.75,
      "evidence": "only negligibly inhibits PDE",
      "source_chunk_ids": [
        "d715fd883cc9d85eb2d357cb456f6fa8"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {
        "action": "modulates"
      },
      "confidence": 0.8,
      "evidence": "modulation of glial inflammatory activity",
      "source_chunk_ids": [
        "d715fd883cc9d85eb2d357cb456f6fa8"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "ACTS_ON",
      "source_entity_id": "E2",
      "target_entity_id": "E7",
      "attributes": {
        "action": "modulates"
      },
      "confidence": 0.8,
      "evidence": "modulation of glial inflammatory activity",
      "source_chunk_ids": [
        "d715fd883cc9d85eb2d357cb456f6fa8"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "contributes to the attenuation of methamphetamine-induced locomotor sensitization",
      "source_chunk_ids": [
        "d715fd883cc9d85eb2d357cb456f6fa8"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "contributes to the attenuation of relapse of drug seeking",
      "source_chunk_ids": [
        "d715fd883cc9d85eb2d357cb456f6fa8"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "TREATS",
      "source_entity_id": "E1",
      "target_entity_id": "E8",
      "attributes": {
        "context": "pharmacotherapy"
      },
      "confidence": 0.75,
      "evidence": "treating methamphetamine abuse",
      "source_chunk_ids": [
        "d715fd883cc9d85eb2d357cb456f6fa8"
      ],
      "supporting_study_ids": [
        "E5"
      ],
      "verified": true
    },
    {
      "id": "R14",
      "type": "TREATS",
      "source_entity_id": "E2",
      "target_entity_id": "E8",
      "attributes": {
        "context": "pharmacotherapy"
      },
      "confidence": 0.75,
      "evidence": "treating methamphetamine abuse",
      "source_chunk_ids": [
        "d715fd883cc9d85eb2d357cb456f6fa8"
      ],
      "supporting_study_ids": [
        "E5"
      ],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "action": "increases"
      },
      "confidence": 0.8,
      "evidence": "increasing extracellular dopamine levels",
      "source_chunk_ids": [
        "ce95485b6ce17ab8aea002931eab6c7c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "ACTS_ON",
      "source_entity_id": "E2",
      "target_entity_id": "E3",
      "attributes": {
        "action": "increases"
      },
      "confidence": 0.8,
      "evidence": "increasing extracellular dopamine levels",
      "source_chunk_ids": [
        "ce95485b6ce17ab8aea002931eab6c7c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E4",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "Anderson and Pierce, 2005",
      "source_chunk_ids": [
        "ce95485b6ce17ab8aea002931eab6c7c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "ACTS_ON",
      "source_entity_id": "E5",
      "target_entity_id": "E6",
      "attributes": {
        "action": "increases"
      },
      "confidence": 0.85,
      "evidence": "rolipram increases striatal cAMP levels",
      "source_chunk_ids": [
        "ce95485b6ce17ab8aea002931eab6c7c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "ACTS_ON",
      "source_entity_id": "E5",
      "target_entity_id": "E7",
      "attributes": {
        "action": "does not alter",
        "outcome": "no_effect"
      },
      "confidence": 0.8,
      "evidence": "does not significantly alter methamphetamine-induced increase",
      "source_chunk_ids": [
        "ce95485b6ce17ab8aea002931eab6c7c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "Iyo et al., 1996",
      "source_chunk_ids": [
        "ce95485b6ce17ab8aea002931eab6c7c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "Iyo et al., 1996",
      "source_chunk_ids": [
        "ce95485b6ce17ab8aea002931eab6c7c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E8",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "In vivo microdialysis shows",
      "source_chunk_ids": [
        "ce95485b6ce17ab8aea002931eab6c7c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "REPORTS",
      "source_entity_id": "E4",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "regulates"
      },
      "confidence": 0.7,
      "evidence": "Regulation of alcohol drinking",
      "source_chunk_ids": [
        "0bc25299772f1d7d19378a920b823f62"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E4",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "reviewed in great detail",
      "source_chunk_ids": [
        "0bc25299772f1d7d19378a920b823f62"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "Reduction of alcohol drinking by PDE4 inhibitors",
      "source_chunk_ids": [
        "9e438a2ab71427981a77ff504eca50bc"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "ACTS_ON",
      "source_entity_id": "E2",
      "target_entity_id": "E3",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "Reduction of alcohol drinking by PDE4 inhibitors",
      "source_chunk_ids": [
        "9e438a2ab71427981a77ff504eca50bc"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Rolipram and Ro 20-1724 reduce alcohol intake",
      "source_chunk_ids": [
        "9e438a2ab71427981a77ff504eca50bc"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Rolipram and Ro 20-1724 reduce alcohol intake",
      "source_chunk_ids": [
        "9e438a2ab71427981a77ff504eca50bc"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Rolipram and Ro 20-1724 reduce alcohol intake",
      "source_chunk_ids": [
        "9e438a2ab71427981a77ff504eca50bc"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Rolipram and Ro 20-1724 reduce alcohol intake",
      "source_chunk_ids": [
        "9e438a2ab71427981a77ff504eca50bc"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Rolipram and Ro 20-1724 reduce alcohol intake and preference",
      "source_chunk_ids": [
        "9e438a2ab71427981a77ff504eca50bc"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Rolipram and Ro 20-1724 reduce alcohol intake and preference",
      "source_chunk_ids": [
        "9e438a2ab71427981a77ff504eca50bc"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E7",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Hu et al., 2011",
      "source_chunk_ids": [
        "9e438a2ab71427981a77ff504eca50bc"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E8",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Wen et al., 2012",
      "source_chunk_ids": [
        "9e438a2ab71427981a77ff504eca50bc"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "STUDIES",
      "source_entity_id": "E7",
      "target_entity_id": "E1",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.75,
      "evidence": "Hu et al., 2011",
      "source_chunk_ids": [
        "9e438a2ab71427981a77ff504eca50bc"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "STUDIES",
      "source_entity_id": "E7",
      "target_entity_id": "E2",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.75,
      "evidence": "Hu et al., 2011",
      "source_chunk_ids": [
        "9e438a2ab71427981a77ff504eca50bc"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "STUDIES",
      "source_entity_id": "E8",
      "target_entity_id": "E1",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.75,
      "evidence": "Wen et al., 2012",
      "source_chunk_ids": [
        "9e438a2ab71427981a77ff504eca50bc"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "Rolipram and Ro 20-1724 reduce alcohol intake",
      "source_chunk_ids": [
        "9e438a2ab71427981a77ff504eca50bc"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R15",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "Rolipram and Ro 20-1724 reduce alcohol intake and preference",
      "source_chunk_ids": [
        "9e438a2ab71427981a77ff504eca50bc"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R16",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "rolipram dose-dependently reduces operant self-administration of alcohol",
      "source_chunk_ids": [
        "9e438a2ab71427981a77ff504eca50bc"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R17",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "chronic rolipram treatment decreases 2-bottle choice alcohol consumption and preference",
      "source_chunk_ids": [
        "9e438a2ab71427981a77ff504eca50bc"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.9,
      "evidence": "non-selective phosphodiesterase inhibitor ibudilast",
      "source_chunk_ids": [
        "b4d61aa725cb159fe54c87b64295c5f8"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "reduces"
      },
      "confidence": 0.85,
      "evidence": "ibudilast reduces 2-bottle choice alcohol drinking",
      "source_chunk_ids": [
        "b4d61aa725cb159fe54c87b64295c5f8"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "reduces"
      },
      "confidence": 0.8,
      "evidence": "reduces 2-bottle choice alcohol drinking and relapse",
      "source_chunk_ids": [
        "b4d61aa725cb159fe54c87b64295c5f8"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E5",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "rodent models",
      "source_chunk_ids": [
        "b4d61aa725cb159fe54c87b64295c5f8"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "STUDIES",
      "source_entity_id": "E5",
      "target_entity_id": "E1",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "ibudilast reduces 2-bottle choice alcohol drinking",
      "source_chunk_ids": [
        "b4d61aa725cb159fe54c87b64295c5f8"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E10",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "reduces"
      },
      "confidence": 0.85,
      "evidence": "selective PDE4 inhibitors reduce ethanol intake",
      "source_chunk_ids": [
        "b4d61aa725cb159fe54c87b64295c5f8"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E11",
      "target_entity_id": "E8",
      "attributes": {
        "outcome": "reduces"
      },
      "confidence": 0.85,
      "evidence": "PDE10A inhibitor TP-10 reduces alcohol self-administration",
      "source_chunk_ids": [
        "b4d61aa725cb159fe54c87b64295c5f8"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "ACTS_ON",
      "source_entity_id": "E9",
      "target_entity_id": "E8",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.9,
      "evidence": "PDE10A inhibitor TP-10",
      "source_chunk_ids": [
        "b4d61aa725cb159fe54c87b64295c5f8"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "TREATS",
      "source_entity_id": "E7",
      "target_entity_id": "E12",
      "attributes": {
        "context": "potential"
      },
      "confidence": 0.75,
      "evidence": "PDE4 are potential therapeutic targets for alcohol dependence",
      "source_chunk_ids": [
        "b4d61aa725cb159fe54c87b64295c5f8"
      ],
      "supporting_study_ids": [
        "E10"
      ],
      "verified": true
    },
    {
      "id": "R10",
      "type": "TREATS",
      "source_entity_id": "E8",
      "target_entity_id": "E12",
      "attributes": {
        "context": "potential"
      },
      "confidence": 0.75,
      "evidence": "PDE10A are potential therapeutic targets for alcohol dependence",
      "source_chunk_ids": [
        "b4d61aa725cb159fe54c87b64295c5f8"
      ],
      "supporting_study_ids": [
        "E11"
      ],
      "verified": true
    },
    {
      "id": "R11",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "PDE inhibitors reduce alcohol drinking",
      "source_chunk_ids": [
        "b4d61aa725cb159fe54c87b64295c5f8"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.9,
      "evidence": "PDE4 inhibitors reduce morphine-induced hyperlocomotor activity",
      "source_chunk_ids": [
        "b89d713905ece27bb27ff3436679ae21"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "rolipram suppresses morphine-induced hyperlocomotion",
      "source_chunk_ids": [
        "b89d713905ece27bb27ff3436679ae21"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "rolipram blocks the acquisition of CPP to morphine",
      "source_chunk_ids": [
        "b89d713905ece27bb27ff3436679ae21"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "rolipram inhibits the discriminative-stimulus effects of morphine",
      "source_chunk_ids": [
        "b89d713905ece27bb27ff3436679ae21"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "morphine-induced hyperlocomotor activity",
      "source_chunk_ids": [
        "b89d713905ece27bb27ff3436679ae21"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "acquisition of CPP to morphine",
      "source_chunk_ids": [
        "b89d713905ece27bb27ff3436679ae21"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "discriminative-stimulus effects of morphine",
      "source_chunk_ids": [
        "b89d713905ece27bb27ff3436679ae21"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E8",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Mori et al., 2000",
      "source_chunk_ids": [
        "b89d713905ece27bb27ff3436679ae21"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E9",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Thompson et al., 2004",
      "source_chunk_ids": [
        "b89d713905ece27bb27ff3436679ae21"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E10",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Yan et al., 2006",
      "source_chunk_ids": [
        "b89d713905ece27bb27ff3436679ae21"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "STUDIES",
      "source_entity_id": "E8",
      "target_entity_id": "E1",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "rolipram suppresses morphine-induced hyperlocomotion",
      "source_chunk_ids": [
        "b89d713905ece27bb27ff3436679ae21"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "STUDIES",
      "source_entity_id": "E9",
      "target_entity_id": "E1",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "rolipram blocks the acquisition of CPP to morphine",
      "source_chunk_ids": [
        "b89d713905ece27bb27ff3436679ae21"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "STUDIES",
      "source_entity_id": "E10",
      "target_entity_id": "E1",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "rolipram inhibits the discriminative-stimulus effects of morphine",
      "source_chunk_ids": [
        "b89d713905ece27bb27ff3436679ae21"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.85,
      "evidence": "rolipram suppresses morphine-induced hyperlocomotion",
      "source_chunk_ids": [
        "b89d713905ece27bb27ff3436679ae21"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R15",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.85,
      "evidence": "rolipram blocks the acquisition of CPP to morphine",
      "source_chunk_ids": [
        "b89d713905ece27bb27ff3436679ae21"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R16",
      "type": "REPORTS",
      "source_entity_id": "E10",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.85,
      "evidence": "rolipram inhibits the discriminative-stimulus effects of morphine",
      "source_chunk_ids": [
        "b89d713905ece27bb27ff3436679ae21"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R17",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {
        "action": "modulates"
      },
      "confidence": 0.7,
      "evidence": "cAMP signaling cascade may play a key role",
      "source_chunk_ids": [
        "b89d713905ece27bb27ff3436679ae21"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.9,
      "evidence": "PDE4 inhibitor rolipram",
      "source_chunk_ids": [
        "53b94c741b1bf38dd8ab9587398b6fc0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "dose-dependently decreases the reward values",
      "source_chunk_ids": [
        "53b94c741b1bf38dd8ab9587398b6fc0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "decreases the cue- and heroin priming-induced reinstatement",
      "source_chunk_ids": [
        "53b94c741b1bf38dd8ab9587398b6fc0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "increases the expression of phosphorylated CREB",
      "source_chunk_ids": [
        "53b94c741b1bf38dd8ab9587398b6fc0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "correlated with its effect on heroin-seeking behavior",
      "source_chunk_ids": [
        "53b94c741b1bf38dd8ab9587398b6fc0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "TREATS",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {
        "context": "potential therapeutic"
      },
      "confidence": 0.8,
      "evidence": "potential therapeutic target for heroin dependence",
      "source_chunk_ids": [
        "53b94c741b1bf38dd8ab9587398b6fc0"
      ],
      "supporting_study_ids": [
        "E9"
      ],
      "verified": true
    },
    {
      "id": "R7",
      "type": "TREATS",
      "source_entity_id": "E1",
      "target_entity_id": "E8",
      "attributes": {
        "context": "potential therapeutic"
      },
      "confidence": 0.8,
      "evidence": "potential therapeutic target for morphine dependence",
      "source_chunk_ids": [
        "53b94c741b1bf38dd8ab9587398b6fc0"
      ],
      "supporting_study_ids": [
        "E9"
      ],
      "verified": true
    },
    {
      "id": "R8",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E9",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Lai et al., 2014",
      "source_chunk_ids": [
        "53b94c741b1bf38dd8ab9587398b6fc0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "STUDIES",
      "source_entity_id": "E9",
      "target_entity_id": "E1",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "rolipram",
      "source_chunk_ids": [
        "53b94c741b1bf38dd8ab9587398b6fc0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "decreases"
      },
      "confidence": 0.85,
      "evidence": "decreases the reward values",
      "source_chunk_ids": [
        "53b94c741b1bf38dd8ab9587398b6fc0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "decreases"
      },
      "confidence": 0.9,
      "evidence": "decreases reinstatement of heroin seeking",
      "source_chunk_ids": [
        "53b94c741b1bf38dd8ab9587398b6fc0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "increases"
      },
      "confidence": 0.85,
      "evidence": "increases phosphorylated CREB expression",
      "source_chunk_ids": [
        "53b94c741b1bf38dd8ab9587398b6fc0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E9",
      "target_entity_id": "E1",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "PDE4 inhibitors rolipram",
      "source_chunk_ids": [
        "9eb6f4d54e0030fe9bdf47faf190909e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "TREATS",
      "source_entity_id": "E9",
      "target_entity_id": "E2",
      "attributes": {
        "context": "preclinical"
      },
      "confidence": 0.8,
      "evidence": "rolipram dampen naloxone-precipitated behavioral signs of morphine withdrawal",
      "source_chunk_ids": [
        "9eb6f4d54e0030fe9bdf47faf190909e"
      ],
      "supporting_study_ids": [
        "E5",
        "E6",
        "E7",
        "E8"
      ],
      "verified": true
    },
    {
      "id": "R3",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Kimura et al., 2006",
      "source_chunk_ids": [
        "9eb6f4d54e0030fe9bdf47faf190909e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "STUDIES",
      "source_entity_id": "E3",
      "target_entity_id": "E1",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.75,
      "evidence": "PDE4 activity",
      "source_chunk_ids": [
        "9eb6f4d54e0030fe9bdf47faf190909e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E3",
      "target_entity_id": "E2",
      "attributes": {
        "outcome": "involves"
      },
      "confidence": 0.7,
      "evidence": "involved in naloxone-precipitated morphine withdrawal symptoms",
      "source_chunk_ids": [
        "9eb6f4d54e0030fe9bdf47faf190909e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E5",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Gonzalez-Cuello et al., 2007",
      "source_chunk_ids": [
        "9eb6f4d54e0030fe9bdf47faf190909e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "STUDIES",
      "source_entity_id": "E5",
      "target_entity_id": "E9",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.8,
      "evidence": "PDE4 inhibitors rolipram",
      "source_chunk_ids": [
        "9eb6f4d54e0030fe9bdf47faf190909e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E10",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.75,
      "evidence": "attenuation of withdrawal syndrome",
      "source_chunk_ids": [
        "9eb6f4d54e0030fe9bdf47faf190909e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E9",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "rolipram dampen withdrawal signs",
      "source_chunk_ids": [
        "9eb6f4d54e0030fe9bdf47faf190909e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "ACTS_ON",
      "source_entity_id": "E9",
      "target_entity_id": "E11",
      "attributes": {
        "action": "up-regulates"
      },
      "confidence": 0.7,
      "evidence": "mediated by the up-regulation of the cAMP signaling",
      "source_chunk_ids": [
        "9eb6f4d54e0030fe9bdf47faf190909e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E6",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Hamdy et al., 2001",
      "source_chunk_ids": [
        "9eb6f4d54e0030fe9bdf47faf190909e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "STUDIES",
      "source_entity_id": "E6",
      "target_entity_id": "E9",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.8,
      "evidence": "rolipram treatment",
      "source_chunk_ids": [
        "9eb6f4d54e0030fe9bdf47faf190909e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "REPORTS",
      "source_entity_id": "E6",
      "target_entity_id": "E12",
      "attributes": {
        "outcome": "blocks"
      },
      "confidence": 0.75,
      "evidence": "blocked the increase in the expression of c-Fos protein",
      "source_chunk_ids": [
        "9eb6f4d54e0030fe9bdf47faf190909e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "PRODUCES",
      "source_entity_id": "E9",
      "target_entity_id": "E13",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "lack of PDE4 activation leads to an increase in levels of cAMP",
      "source_chunk_ids": [
        "9eb6f4d54e0030fe9bdf47faf190909e"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "TREATS",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "context": "mechanistic"
      },
      "confidence": 0.8,
      "evidence": "PDE4 inhibitors reduce opioid-induced respiratory depression",
      "source_chunk_ids": [
        "80f190250acd8f566c4344404c65092c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Kimura et al., 2015",
      "source_chunk_ids": [
        "80f190250acd8f566c4344404c65092c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "STUDIES",
      "source_entity_id": "E3",
      "target_entity_id": "E5",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "intravenous injection of rolipram",
      "source_chunk_ids": [
        "80f190250acd8f566c4344404c65092c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E3",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "blocks"
      },
      "confidence": 0.85,
      "evidence": "blocked morphine-induced prolongation",
      "source_chunk_ids": [
        "80f190250acd8f566c4344404c65092c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E3",
      "target_entity_id": "E8",
      "attributes": {
        "outcome": "no_effect"
      },
      "confidence": 0.8,
      "evidence": "not did not affect morphine-induced suppression",
      "source_chunk_ids": [
        "80f190250acd8f566c4344404c65092c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "ACTS_ON",
      "source_entity_id": "E5",
      "target_entity_id": "E9",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.75,
      "evidence": "inhibition of PDE4",
      "source_chunk_ids": [
        "80f190250acd8f566c4344404c65092c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "morphine-induced ventilatory depression",
      "source_chunk_ids": [
        "80f190250acd8f566c4344404c65092c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "morphine-induced suppression",
      "source_chunk_ids": [
        "80f190250acd8f566c4344404c65092c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "action": "part of"
      },
      "confidence": 0.85,
      "evidence": "c-Fos is part of the AP-1 transcription complex",
      "source_chunk_ids": [
        "a812b8d01d3567df5b0b6d3914f3c92c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "results in activation of signaling cascades",
      "source_chunk_ids": [
        "a812b8d01d3567df5b0b6d3914f3c92c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "important in synaptic and behavioral plasticity",
      "source_chunk_ids": [
        "a812b8d01d3567df5b0b6d3914f3c92c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "ACTS_ON",
      "source_entity_id": "E6",
      "target_entity_id": "E1",
      "attributes": {
        "action": "induces expression",
        "outcome": "no_effect"
      },
      "confidence": 0.75,
      "evidence": "cocaine-induced expression of c-Fos",
      "source_chunk_ids": [
        "a812b8d01d3567df5b0b6d3914f3c92c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "ACTS_ON",
      "source_entity_id": "E5",
      "target_entity_id": "E7",
      "attributes": {
        "action": "no effect",
        "outcome": "no_effect"
      },
      "confidence": 0.8,
      "evidence": "rolipram has no effect on cocaine-induced expression",
      "source_chunk_ids": [
        "a812b8d01d3567df5b0b6d3914f3c92c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "ACTS_ON",
      "source_entity_id": "E5",
      "target_entity_id": "E1",
      "attributes": {
        "action": "increases levels"
      },
      "confidence": 0.75,
      "evidence": "rolipram itself increases levels in the nucleus accumbens shell",
      "source_chunk_ids": [
        "a812b8d01d3567df5b0b6d3914f3c92c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "rolipram itself increases levels in the nucleus accumbens shell",
      "source_chunk_ids": [
        "a812b8d01d3567df5b0b6d3914f3c92c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E9",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Thompson et al., 2004",
      "source_chunk_ids": [
        "a812b8d01d3567df5b0b6d3914f3c92c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "STUDIES",
      "source_entity_id": "E9",
      "target_entity_id": "E5",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "rolipram has no effect on cocaine-induced expression",
      "source_chunk_ids": [
        "a812b8d01d3567df5b0b6d3914f3c92c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "no_effect"
      },
      "confidence": 0.8,
      "evidence": "rolipram has no effect on cocaine-induced expression",
      "source_chunk_ids": [
        "a812b8d01d3567df5b0b6d3914f3c92c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E8",
      "attributes": {
        "outcome": "increases"
      },
      "confidence": 0.75,
      "evidence": "rolipram itself increases levels in the nucleus accumbens shell",
      "source_chunk_ids": [
        "a812b8d01d3567df5b0b6d3914f3c92c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "action": "modulates"
      },
      "confidence": 0.75,
      "evidence": "PDE activity can modulate the reinforcing effect",
      "source_chunk_ids": [
        "c6daedd4d0f94e8bf3c21d0b937492eb"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {
        "action": "decreases"
      },
      "confidence": 0.85,
      "evidence": "Infusion of rolipram decreases the threshold",
      "source_chunk_ids": [
        "c6daedd4d0f94e8bf3c21d0b937492eb"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E6",
      "attributes": {
        "action": "enhances"
      },
      "confidence": 0.8,
      "evidence": "rolipram enhances the effects of systemic cocaine",
      "source_chunk_ids": [
        "c6daedd4d0f94e8bf3c21d0b937492eb"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "cocaine on lowering the threshold",
      "source_chunk_ids": [
        "c6daedd4d0f94e8bf3c21d0b937492eb"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E7",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Knapp et al., 2001",
      "source_chunk_ids": [
        "c6daedd4d0f94e8bf3c21d0b937492eb"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "STUDIES",
      "source_entity_id": "E7",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "Infusion of rolipram",
      "source_chunk_ids": [
        "c6daedd4d0f94e8bf3c21d0b937492eb"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "observed"
      },
      "confidence": 0.8,
      "evidence": "decreases the threshold",
      "source_chunk_ids": [
        "c6daedd4d0f94e8bf3c21d0b937492eb"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "observed"
      },
      "confidence": 0.75,
      "evidence": "enhances the effects of systemic cocaine",
      "source_chunk_ids": [
        "c6daedd4d0f94e8bf3c21d0b937492eb"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "ACTS_ON",
      "source_entity_id": "E9",
      "target_entity_id": "E10",
      "attributes": {
        "action": "enhances"
      },
      "confidence": 0.7,
      "evidence": "increasing the activity of cAMP pathways may enhance",
      "source_chunk_ids": [
        "c6daedd4d0f94e8bf3c21d0b937492eb"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "Incubation of heroin craving",
      "source_chunk_ids": [
        "7fe5167426c0f3fa249523c61eea8303"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E2",
      "attributes": {
        "outcome": "associated"
      },
      "confidence": 0.8,
      "evidence": "Incubation of heroin craving",
      "source_chunk_ids": [
        "7fe5167426c0f3fa249523c61eea8303"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "decreased"
      },
      "confidence": 0.85,
      "evidence": "decreased phosphorylated CREB (pCREB)",
      "source_chunk_ids": [
        "7fe5167426c0f3fa249523c61eea8303"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "location"
      },
      "confidence": 0.9,
      "evidence": "in the nucleus accumbens",
      "source_chunk_ids": [
        "7fe5167426c0f3fa249523c61eea8303"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "STUDIES",
      "source_entity_id": "E8",
      "target_entity_id": "E5",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "intra-accumbens rolipram",
      "source_chunk_ids": [
        "7fe5167426c0f3fa249523c61eea8303"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.85,
      "evidence": "rolipram reduced drug seeking",
      "source_chunk_ids": [
        "7fe5167426c0f3fa249523c61eea8303"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "increases"
      },
      "confidence": 0.85,
      "evidence": "increased local pCREB levels",
      "source_chunk_ids": [
        "7fe5167426c0f3fa249523c61eea8303"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E8",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "intra-accumbens rolipram",
      "source_chunk_ids": [
        "7fe5167426c0f3fa249523c61eea8303"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "ACTS_ON",
      "source_entity_id": "E5",
      "target_entity_id": "E3",
      "attributes": {
        "action": "increases"
      },
      "confidence": 0.75,
      "evidence": "increased local pCREB levels",
      "source_chunk_ids": [
        "7fe5167426c0f3fa249523c61eea8303"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "TREATS",
      "source_entity_id": "E5",
      "target_entity_id": "E2",
      "attributes": {
        "context": "experimental"
      },
      "confidence": 0.7,
      "evidence": "rolipram reduced drug seeking",
      "source_chunk_ids": [
        "7fe5167426c0f3fa249523c61eea8303"
      ],
      "supporting_study_ids": [
        "E8"
      ],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Zhong et al., 2012",
      "source_chunk_ids": [
        "bffa1ced7228afd9a051ecf8de97e02d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "intra-VTA injection of rolipram",
      "source_chunk_ids": [
        "bffa1ced7228afd9a051ecf8de97e02d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "PDE4 inhibition",
      "source_chunk_ids": [
        "bffa1ced7228afd9a051ecf8de97e02d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "prevents"
      },
      "confidence": 0.85,
      "evidence": "blocked the acquisition of cocaine CPP",
      "source_chunk_ids": [
        "bffa1ced7228afd9a051ecf8de97e02d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "no_effect"
      },
      "confidence": 0.85,
      "evidence": "did not affect the expression of cocaine CPP",
      "source_chunk_ids": [
        "bffa1ced7228afd9a051ecf8de97e02d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "cocaine CPP",
      "source_chunk_ids": [
        "bffa1ced7228afd9a051ecf8de97e02d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E4",
      "target_entity_id": "E5",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "activation leads to the inhibition of adenylyl cyclase",
      "source_chunk_ids": [
        "e479cb817091711ddd4d2c74e216604f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E6",
      "attributes": {
        "action": "decreases"
      },
      "confidence": 0.8,
      "evidence": "resulting in decreased cAMP/PKA activity",
      "source_chunk_ids": [
        "e479cb817091711ddd4d2c74e216604f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E7",
      "target_entity_id": "E6",
      "attributes": {
        "action": "enhances"
      },
      "confidence": 0.85,
      "evidence": "PDE4 inhibition is known to enhance cAMP levels",
      "source_chunk_ids": [
        "e479cb817091711ddd4d2c74e216604f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "ACTS_ON",
      "source_entity_id": "E8",
      "target_entity_id": "E2",
      "attributes": {
        "action": "blocks"
      },
      "confidence": 0.9,
      "evidence": "PDE4 inhibitors rolipram and Ro 20-1724 blocked endocannabinoid I-LTD",
      "source_chunk_ids": [
        "e479cb817091711ddd4d2c74e216604f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "ACTS_ON",
      "source_entity_id": "E9",
      "target_entity_id": "E2",
      "attributes": {
        "action": "blocks"
      },
      "confidence": 0.9,
      "evidence": "PDE4 inhibitors rolipram and Ro 20-1724 blocked endocannabinoid I-LTD",
      "source_chunk_ids": [
        "e479cb817091711ddd4d2c74e216604f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E12",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "blockade of cocaine-induced inhibitory synaptic plasticity is a likely cellular mechanism by which PDE4 inhibition impairs CPP to cocaine",
      "source_chunk_ids": [
        "e479cb817091711ddd4d2c74e216604f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E15",
      "target_entity_id": "E16",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "in VTA dopamine neurons",
      "source_chunk_ids": [
        "e479cb817091711ddd4d2c74e216604f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "STUDIES",
      "source_entity_id": "E15",
      "target_entity_id": "E8",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "PDE4 inhibitors rolipram and Ro 20-1724",
      "source_chunk_ids": [
        "e479cb817091711ddd4d2c74e216604f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "STUDIES",
      "source_entity_id": "E15",
      "target_entity_id": "E9",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "PDE4 inhibitors rolipram and Ro 20-1724",
      "source_chunk_ids": [
        "e479cb817091711ddd4d2c74e216604f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "REPORTS",
      "source_entity_id": "E15",
      "target_entity_id": "E12",
      "attributes": {
        "outcome": "observed"
      },
      "confidence": 0.8,
      "evidence": "blocked endocannabinoid I-LTD and synaptic depression",
      "source_chunk_ids": [
        "e479cb817091711ddd4d2c74e216604f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "REPORTS",
      "source_entity_id": "E15",
      "target_entity_id": "E13",
      "attributes": {
        "outcome": "suggests"
      },
      "confidence": 0.75,
      "evidence": "impairs CPP to cocaine",
      "source_chunk_ids": [
        "e479cb817091711ddd4d2c74e216604f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "TREATS",
      "source_entity_id": "E5",
      "target_entity_id": "E2",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.85,
      "evidence": "PDE4 inhibitors have been approved for the treatment of COPD",
      "source_chunk_ids": [
        "a066a69009569bacd4df52d66c844bee"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "TREATS",
      "source_entity_id": "E5",
      "target_entity_id": "E3",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.85,
      "evidence": "PDE4 inhibitors have been approved for the treatment of inflammatory diseases",
      "source_chunk_ids": [
        "a066a69009569bacd4df52d66c844bee"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "SUGGESTS",
      "source_entity_id": "E5",
      "target_entity_id": "E4",
      "attributes": {
        "mapping_type": "direct"
      },
      "confidence": 0.8,
      "evidence": "repurpose these PDE4 inhibitors for the treatment of drug addiction",
      "source_chunk_ids": [
        "a066a69009569bacd4df52d66c844bee"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_CLASS",
      "source_entity_id": "E2",
      "target_entity_id": "E1",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "PDE4 inhibitors such as rolipram",
      "source_chunk_ids": [
        "4b1724b03dc618f80a443b41b0133ca0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "CAUSES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "cause nausea",
      "source_chunk_ids": [
        "4b1724b03dc618f80a443b41b0133ca0"
      ],
      "supporting_study_ids": [
        "E8"
      ],
      "verified": true
    },
    {
      "id": "R3",
      "type": "CAUSES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "cause emesis",
      "source_chunk_ids": [
        "4b1724b03dc618f80a443b41b0133ca0"
      ],
      "supporting_study_ids": [
        "E8"
      ],
      "verified": true
    },
    {
      "id": "R4",
      "type": "ACTS_ON",
      "source_entity_id": "E2",
      "target_entity_id": "E5",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.75,
      "evidence": "PDE4 inhibitors such as rolipram",
      "source_chunk_ids": [
        "4b1724b03dc618f80a443b41b0133ca0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "cause nausea",
      "source_chunk_ids": [
        "4b1724b03dc618f80a443b41b0133ca0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "cause emesis",
      "source_chunk_ids": [
        "4b1724b03dc618f80a443b41b0133ca0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "PDE4 expressed in the area postrema",
      "source_chunk_ids": [
        "4b1724b03dc618f80a443b41b0133ca0"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E2",
      "target_entity_id": "E3",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.8,
      "evidence": "PDE4B inhibitors may represent an effective means to reduce drug seeking behavior",
      "source_chunk_ids": [
        "a5db36073075bb0ff21936c65889e93c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "CAUSES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "context": "pharmacological"
      },
      "confidence": 0.85,
      "evidence": "emetic effects of PDE4 inhibitors that are mediated by activation of the PDE4D",
      "source_chunk_ids": [
        "a5db36073075bb0ff21936c65889e93c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E2",
      "target_entity_id": "E5",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.8,
      "evidence": "PDE4B inhibitors exhibited potent anti-inflammatory effects in vivo",
      "source_chunk_ids": [
        "a5db36073075bb0ff21936c65889e93c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "ACTS_ON",
      "source_entity_id": "E2",
      "target_entity_id": "E6",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.75,
      "evidence": "PDE4B inhibition may also have effects on generalized anxiety",
      "source_chunk_ids": [
        "a5db36073075bb0ff21936c65889e93c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "ACTS_ON",
      "source_entity_id": "E2",
      "target_entity_id": "E7",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.7,
      "evidence": "influence drug craving during abstinence",
      "source_chunk_ids": [
        "a5db36073075bb0ff21936c65889e93c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E8",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "Knockout of a large region of the catalytic domain resulted in increased anxiety-like behavior",
      "source_chunk_ids": [
        "a5db36073075bb0ff21936c65889e93c"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E9",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "reduction of cAMP hydrolyzation via Y358C substitution reduced anxiety-like behavior",
      "source_chunk_ids": [
        "a5db36073075bb0ff21936c65889e93c"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R8",
      "type": "REPORTS",
      "source_entity_id": "E10",
      "target_entity_id": "E1",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "PDE4D is expressed in many parts of the brain (Cherry and Davis, 1999)",
      "source_chunk_ids": [
        "a5db36073075bb0ff21936c65889e93c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "REPORTS",
      "source_entity_id": "E11",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "PDE4B inhibitors exhibited potent anti-inflammatory effects in vivo (Hagen et al., 2014)",
      "source_chunk_ids": [
        "a5db36073075bb0ff21936c65889e93c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "REPORTS",
      "source_entity_id": "E12",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "PDE4B inhibitors exhibited potent anti-inflammatory effects in vivo (Naganuma et al., 2009)",
      "source_chunk_ids": [
        "a5db36073075bb0ff21936c65889e93c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "REPORTS",
      "source_entity_id": "E13",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Knockout resulted in increased anxiety-like behavior (Zhang et al., 2008)",
      "source_chunk_ids": [
        "a5db36073075bb0ff21936c65889e93c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "REPORTS",
      "source_entity_id": "E14",
      "target_entity_id": "E8",
      "attributes": {
        "assertion": "refutes"
      },
      "confidence": 0.75,
      "evidence": "no difference in the elevated plus maze (Siuciak et al., 2008)",
      "source_chunk_ids": [
        "a5db36073075bb0ff21936c65889e93c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "REPORTS",
      "source_entity_id": "E15",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "reduced anxiety-like behavior (McGirr et al., 2016)",
      "source_chunk_ids": [
        "a5db36073075bb0ff21936c65889e93c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E10",
      "target_entity_id": "E16",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "inferred from context",
      "source_chunk_ids": [
        "a5db36073075bb0ff21936c65889e93c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R15",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E11",
      "target_entity_id": "E17",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "exhibited potent anti-inflammatory effects in vivo",
      "source_chunk_ids": [
        "a5db36073075bb0ff21936c65889e93c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R16",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E12",
      "target_entity_id": "E17",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "exhibited potent anti-inflammatory effects in vivo",
      "source_chunk_ids": [
        "a5db36073075bb0ff21936c65889e93c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R17",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E13",
      "target_entity_id": "E18",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "Knockout of a large region of the catalytic domain",
      "source_chunk_ids": [
        "a5db36073075bb0ff21936c65889e93c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R18",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E14",
      "target_entity_id": "E18",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "no difference in the elevated plus maze",
      "source_chunk_ids": [
        "a5db36073075bb0ff21936c65889e93c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R19",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E15",
      "target_entity_id": "E18",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "reduction of cAMP hydrolyzation via Y358C substitution",
      "source_chunk_ids": [
        "a5db36073075bb0ff21936c65889e93c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E2",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "animal study in C57BL/6J mice",
      "source_chunk_ids": [
        "16c2fe25d90b39e6a907e434c40fd469"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E2",
      "target_entity_id": "E1",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.9,
      "evidence": "Inhibition of phosphodiesterase 4",
      "source_chunk_ids": [
        "16c2fe25d90b39e6a907e434c40fd469"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E2",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.85,
      "evidence": "reduces ethanol intake and preference",
      "source_chunk_ids": [
        "16c2fe25d90b39e6a907e434c40fd469"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E2",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "ethanol intake and preference",
      "source_chunk_ids": [
        "16c2fe25d90b39e6a907e434c40fd469"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E6",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "animal study in rats",
      "source_chunk_ids": [
        "16c2fe25d90b39e6a907e434c40fd469"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "STUDIES",
      "source_entity_id": "E6",
      "target_entity_id": "E1",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.9,
      "evidence": "targeting phosphodiesterase-4 (PDE4)",
      "source_chunk_ids": [
        "16c2fe25d90b39e6a907e434c40fd469"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E6",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.85,
      "evidence": "Reduction of alcohol drinking",
      "source_chunk_ids": [
        "16c2fe25d90b39e6a907e434c40fd469"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E8",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "multicenter double-blind study",
      "source_chunk_ids": [
        "16c2fe25d90b39e6a907e434c40fd469"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "STUDIES",
      "source_entity_id": "E8",
      "target_entity_id": "E10",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "cAMP-phosphodiesterase inhibitor rolipram",
      "source_chunk_ids": [
        "16c2fe25d90b39e6a907e434c40fd469"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E11",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.85,
      "evidence": "patients with major depressive disorder",
      "source_chunk_ids": [
        "16c2fe25d90b39e6a907e434c40fd469"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "ACTS_ON",
      "source_entity_id": "E10",
      "target_entity_id": "E1",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.8,
      "evidence": "cAMP-phosphodiesterase inhibitor rolipram",
      "source_chunk_ids": [
        "16c2fe25d90b39e6a907e434c40fd469"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E12",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "animal study in mice",
      "source_chunk_ids": [
        "16c2fe25d90b39e6a907e434c40fd469"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "STUDIES",
      "source_entity_id": "E12",
      "target_entity_id": "E10",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "selective phosphodiesterase IV inhibitor, rolipram",
      "source_chunk_ids": [
        "16c2fe25d90b39e6a907e434c40fd469"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "REPORTS",
      "source_entity_id": "E12",
      "target_entity_id": "E13",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.85,
      "evidence": "blocks both withdrawal behavioral manifestations",
      "source_chunk_ids": [
        "16c2fe25d90b39e6a907e434c40fd469"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R15",
      "type": "REPORTS",
      "source_entity_id": "E12",
      "target_entity_id": "E14",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "morphine dependent mice",
      "source_chunk_ids": [
        "16c2fe25d90b39e6a907e434c40fd469"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R16",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E15",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "animal study",
      "source_chunk_ids": [
        "16c2fe25d90b39e6a907e434c40fd469"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R17",
      "type": "STUDIES",
      "source_entity_id": "E15",
      "target_entity_id": "E10",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "Phosphodiesterase 4 inhibitors, rolipram",
      "source_chunk_ids": [
        "16c2fe25d90b39e6a907e434c40fd469"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R18",
      "type": "STUDIES",
      "source_entity_id": "E15",
      "target_entity_id": "E17",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "rolipram and diazepam",
      "source_chunk_ids": [
        "16c2fe25d90b39e6a907e434c40fd469"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R19",
      "type": "REPORTS",
      "source_entity_id": "E15",
      "target_entity_id": "E16",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "block the adaptive changes observed during morphine withdrawal in the heart",
      "source_chunk_ids": [
        "16c2fe25d90b39e6a907e434c40fd469"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "PDE4 inhibitors rolipram",
      "source_chunk_ids": [
        "109a66f50c7a6ac2fa180c17a6ad0933"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "ACTS_ON",
      "source_entity_id": "E2",
      "target_entity_id": "E3",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "PDE4 inhibitors Ro 20-1724",
      "source_chunk_ids": [
        "109a66f50c7a6ac2fa180c17a6ad0933"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "blocked by rolipram",
      "source_chunk_ids": [
        "109a66f50c7a6ac2fa180c17a6ad0933"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "blocked by Ro 20-1724",
      "source_chunk_ids": [
        "109a66f50c7a6ac2fa180c17a6ad0933"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "cocaine induces I-LTD",
      "source_chunk_ids": [
        "109a66f50c7a6ac2fa180c17a6ad0933"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "quinpirole induces I-LTD",
      "source_chunk_ids": [
        "109a66f50c7a6ac2fa180c17a6ad0933"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.9,
      "evidence": "PDE4 inhibitors rolipram",
      "source_chunk_ids": [
        "e03dc3ab5ee086ee9a8fa852c4564f9c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "ACTS_ON",
      "source_entity_id": "E2",
      "target_entity_id": "E5",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.9,
      "evidence": "PDE4 inhibitors Ro 20-1724",
      "source_chunk_ids": [
        "e03dc3ab5ee086ee9a8fa852c4564f9c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E4",
      "target_entity_id": "E6",
      "attributes": {
        "action": "agonist"
      },
      "confidence": 0.85,
      "evidence": "D2 receptor agonist quinpirole",
      "source_chunk_ids": [
        "e03dc3ab5ee086ee9a8fa852c4564f9c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "cocaine induced I-LTD in VTA dopamine neurons",
      "source_chunk_ids": [
        "e03dc3ab5ee086ee9a8fa852c4564f9c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "quinpirole induced I-LTD in VTA dopamine neurons",
      "source_chunk_ids": [
        "e03dc3ab5ee086ee9a8fa852c4564f9c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "rolipram blocked I-LTD",
      "source_chunk_ids": [
        "e03dc3ab5ee086ee9a8fa852c4564f9c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Ro 20-1724 blocked I-LTD",
      "source_chunk_ids": [
        "e03dc3ab5ee086ee9a8fa852c4564f9c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E9",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "in vitro whole-cell recordings",
      "source_chunk_ids": [
        "e03dc3ab5ee086ee9a8fa852c4564f9c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "STUDIES",
      "source_entity_id": "E9",
      "target_entity_id": "E1",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.75,
      "evidence": "tested rolipram effects",
      "source_chunk_ids": [
        "e03dc3ab5ee086ee9a8fa852c4564f9c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "STUDIES",
      "source_entity_id": "E9",
      "target_entity_id": "E2",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.75,
      "evidence": "tested Ro 20-1724 effects",
      "source_chunk_ids": [
        "e03dc3ab5ee086ee9a8fa852c4564f9c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "STUDIES",
      "source_entity_id": "E9",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.75,
      "evidence": "tested cocaine effects",
      "source_chunk_ids": [
        "e03dc3ab5ee086ee9a8fa852c4564f9c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "STUDIES",
      "source_entity_id": "E9",
      "target_entity_id": "E4",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.75,
      "evidence": "tested quinpirole effects",
      "source_chunk_ids": [
        "e03dc3ab5ee086ee9a8fa852c4564f9c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "induces"
      },
      "confidence": 0.8,
      "evidence": "reports I-LTD induction",
      "source_chunk_ids": [
        "e03dc3ab5ee086ee9a8fa852c4564f9c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E8",
      "attributes": {
        "outcome": "blocks"
      },
      "confidence": 0.8,
      "evidence": "reports I-LTD blockade",
      "source_chunk_ids": [
        "e03dc3ab5ee086ee9a8fa852c4564f9c"
      ],
      "supporting_study_ids": [],
      "verified": true
    }
  ]
}